<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosbiol</journal-id><journal-title-group><journal-title>PLoS Biology</journal-title></journal-title-group><issn pub-type="ppub">1544-9173</issn><issn pub-type="epub">1545-7885</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PLBI-RA-4143R3</article-id><article-id pub-id-type="doi">10.1371/journal.pbio.1000181</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Genetics and Genomics/Gene Expression</subject><subject>Genetics and Genomics/Gene Expression</subject><subject>Molecular Biology</subject><subject>Molecular Biology</subject><subject>Physiology</subject><subject>Physiology</subject></subj-group></article-categories><title-group><article-title>REV-ERB&#x003b1; Participates in Circadian SREBP Signaling and Bile Acid Homeostasis</article-title><alt-title alt-title-type="running-head">Circadian Control of the SREBP Pathway by REV-ERB&#x003b1;</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Le Martelot</surname><given-names>Gwendal</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Claudel</surname><given-names>Thierry</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gatfield</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schaad</surname><given-names>Olivier</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kornmann</surname><given-names>Beno&#x000ee;t</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn1"><sup>&#x000a4;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sasso</surname><given-names>Giuseppe Lo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Moschetta</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schibler</surname><given-names>Ueli</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Molecular Biology and NCCR Frontiers in Genetics, Sciences III, University of Geneva, Geneva, Switzerland</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Laboratory of Experimental and Molecular Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Laboratory of Lipid Metabolism and Cancer, Consorzio Mario Negri Sud, Santa Maria Imbaro (Chieti) and Clinica Medica Murri, University of Bari, Italy</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Vidal-Puig</surname><given-names>Antonio J.</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Cambridge, United Kingdom</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>Ueli.schibler@unige.ch</email></corresp><fn fn-type="con"><p>The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: GLM TC US. Performed the experiments: GLM TC GLS. Analyzed the data: GLM TC DG OS AM US. Contributed reagents/materials/analysis tools: GLM TC BK AM US. Wrote the paper: GLM DG US.</p></fn><fn id="fn1" fn-type="current-aff"><label>&#x000a4;</label><p>Current address: Howard Hughes Medical Institute, University of California at San Francisco, San Francisco, California, United States of America</p></fn></author-notes><pub-date pub-type="collection"><month>9</month><year>2009</year></pub-date><!-- Fake ppub added to accomodate plos workflow change from 03/2008 and 03/2009 --><pub-date pub-type="ppub"><month>9</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>1</day><month>9</month><year>2009</year></pub-date><volume>7</volume><issue>9</issue><elocation-id>e1000181</elocation-id><history><date date-type="received"><day>25</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>16</day><month>7</month><year>2009</year></date></history><permissions><copyright-statement>Le Martelot et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement></permissions><abstract abstract-type="toc"><p>The nuclear receptor REV-ERB&#x003b1; shapes the daily activity profile of Sterol Response Element Binding Protein (SREBP) and thereby participates in the circadian control of cholesterol and bile acid synthesis in the liver.</p></abstract><abstract><p>In mammals, many aspects of behavior and physiology, and in particular cellular metabolism, are coordinated by the circadian timing system. Molecular clocks are thought to rely on negative feedback loops in clock gene expression that engender oscillations in the accumulation of transcriptional regulatory proteins, such as the orphan receptor REV-ERB&#x003b1;. Circadian transcription factors then drive daily rhythms in the expression of clock-controlled output genes, for example genes encoding enzymes and regulators of cellular metabolism. To gain insight into clock output functions of REV-ERB&#x003b1;, we carried out genome-wide transcriptome profiling experiments with liver RNA from wild-type mice, <italic>Rev-erb</italic>&#x003b1; knock-out mice, or REV-ERB&#x003b1; overexpressing mice. On the basis of these genetic loss- and gain-of-function experiments, we concluded that REV-ERB&#x003b1; participates in the circadian modulation of sterol regulatory element-binding protein (SREBP) activity, and thereby in the daily expression of SREBP target genes involved in cholesterol and lipid metabolism. This control is exerted via the cyclic transcription of <italic>Insig2</italic>, encoding a trans-membrane protein that sequesters SREBP proteins to the endoplasmic reticulum membranes and thereby interferes with the proteolytic activation of SREBPs in Golgi membranes. REV-ERB&#x003b1; also participates in the cyclic expression of cholesterol-7&#x003b1;-hydroxylase (CYP7A1), the rate-limiting enzyme in converting cholesterol to bile acids. Our findings suggest that this control acts via the stimulation of LXR nuclear receptors by cyclically produced oxysterols. In conclusion, our study suggests that rhythmic cholesterol and bile acid metabolism is not just driven by alternating feeding&#x02013;fasting cycles, but also by REV-ERB&#x003b1;, a component of the circadian clockwork circuitry.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>The mammalian circadian timing system has a hierarchical architecture: a central pacemaker in the brain's suprachiasmatic nucleus (SCN) synchronizes subsidiary oscillators present in most peripheral cell types. In both SCN neurons and peripheral cells, circadian oscillators are thought to rely on two negative feedback loops. A major feedback loop involves the two cryptochromes CRY1 and CRY2 and the two period proteins PER1 and PER2, which serve as transcriptional repressors for their own genes. An accessory feedback loop couples the expression and activity of the transcriptional activators CLOCK and BMAL1 to the expression of cryptochrome and period proteins. The orphan nuclear receptor REV-ERB&#x003b1; is a key player in this accessory feedback loop, in that it periodically represses <italic>Bmal1</italic> transcription. In liver, molecular clocks mediate the temporal gating of metabolic processes. Here we demonstrate that hepatocyte clocks participate in the control of cholesterol and bile acid homeostasis. According to this scenario, REV-ERB&#x003b1; shapes the circadian expression pattern of insulin-induced gene 2 (INSIG2), a resident protein of the endoplasmic reticulum that interferes with the proteolytic activation of sterol response element binding proteins (SREBPs). In turn SREBPs govern the rhythmic expression of enzymes with key functions in sterol and fatty acid synthesis. The circadian production of sterols (in particular oxysterols) may engender the cyclic activation of LXR nuclear receptors, which serve as critical activators of <italic>Cyp7a1</italic> transcription. CYP7A1, also known as cholesterol 7&#x003b1;-hydroxylase, catalyzes the rate-limiting step in bile acid synthesis.</p></abstract><counts><page-count count="12"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Virtually all light-sensitive organisms from cyanobacteria to humans possess circadian clocks that allow them to anticipate environmental changes and thus to adapt their behavior and physiology accordingly. The mammalian circadian timing system has a hierarchical structure, in that daily light-dark cycles phase-entrain the master clock in the suprachiasmatic nucleus (SCN), which in turn synchronizes subsidiary oscillators in most peripheral cells <xref ref-type="bibr" rid="pbio.1000181-Gachon1">&#x0005b;1&#x0005d;</xref>,<xref ref-type="bibr" rid="pbio.1000181-Reppert1">&#x0005b;2&#x0005d;</xref>. How the SCN signals to peripheral organs to entrain their oscillators is still poorly understood, but daily feeding&#x02013;fasting cycles, body temperature oscillations, and SCN-controlled circadian hormone rhythms appear to play a central role in this process <xref ref-type="bibr" rid="pbio.1000181-Balsalobre1">&#x0005b;3&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pbio.1000181-Stokkan1">&#x0005b;6&#x0005d;</xref>.</p><p>In both the SCN and in the periphery, the circadian oscillator is thought to be based on a negative transcriptional/translational feedback loop involving multiple clock components, notably members of the Period (PER1, PER2) and Cryptochrome (CRY1, CRY2) protein families. These proteins rhythmically inhibit their own transcription by interfering with the transactivation potential of CLOCK/NPAS2&#x02236;BMAL1 heterodimers <xref ref-type="bibr" rid="pbio.1000181-Reppert1">&#x0005b;2&#x0005d;</xref>,<xref ref-type="bibr" rid="pbio.1000181-DeBruyne1">&#x0005b;7&#x0005d;</xref>. The circadian transcription of the gene encoding the nuclear orphan receptor REV-ERB&#x003b1; is regulated by a similar mechanism, in that it is activated by CLOCK&#x02236;BMAL1 and repressed by PER&#x02236;CRY complexes. The periodic accumulation of REV-ERB&#x003b1; provokes the cyclic repression of the essential clock gene <italic>Bmal1</italic><xref ref-type="bibr" rid="pbio.1000181-Preitner1">&#x0005b;8&#x0005d;</xref>. REV-ERB&#x003b1; thus couples the so-called positive and negative limbs of the molecular oscillator. Transcriptome profiling studies on wild-type and mice defective for core oscillator components have uncovered that the core clock also regulates the rhythmic activity of circadian output genes, which account for overt circadian rhythms in physiology and behaviour <xref ref-type="bibr" rid="pbio.1000181-Akhtar1">&#x0005b;9&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pbio.1000181-Storch1">&#x0005b;13&#x0005d;</xref>. For example, CLOCK&#x02236;BMAL1 in the liver drives the cyclic expression of the transcription factors of the proline- and acid-rich basic region leucin zipper (PAR bZIP) family albumin D-site-binding protein (DBP), thyrotroph embryonic factor (TEF), and hepatic leukemia factor (HLF), which in turn regulate the transcription of genes encoding detoxification enzymes <xref ref-type="bibr" rid="pbio.1000181-Gachon2">&#x0005b;14&#x0005d;</xref>.</p><p>Hepatic cholesterol and bile acid synthesis have long been known to be subject to circadian regulation <xref ref-type="bibr" rid="pbio.1000181-Gielen1">&#x0005b;15&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pbio.1000181-Edwards1">&#x0005b;17&#x0005d;</xref>. During the activity phase, when animals absorb food, large amounts of cholesterol are converted into bile acids, which are secreted into the gut as emulsifiers of lipids. To ensure cholesterol homeostasis, the intracellular cholesterol pool has to be replenished. Conversion of cholesterol into bile acid must therefore be tightly coordinated during the day, and transcription of genes encoding key enzymes of cholesterol metabolism are indeed highly circadian.</p><p>Cholesterol availability is sensed in membranes of the endoplasmic reticulum (ER) by the sterol regulatory element-binding protein (SREBP)-cleavage activating protein (SCAP)-INSIG-SREBP complex. SREBP members belong to the basic helix-loop-helix leucine zipper (bHLH-LZ) transcription factor family. While SREBP-2 controls genes involved in cholesterol synthesis, such as <italic>Hmg-CoA reductase</italic> (<italic>Hmgcr</italic>) <xref ref-type="bibr" rid="pbio.1000181-Vallett1">&#x0005b;18&#x0005d;</xref>, SREBP-1c mainly regulates genes implicated in lipogenesis, such as the gene encoding fatty acid synthase (FAS) <xref ref-type="bibr" rid="pbio.1000181-Magana1">&#x0005b;19&#x0005d;</xref>. SREBPs are synthesized as inactive precursors anchored in the ER membrane via two transmembrane domains, where they bind to the eight-transmembrane domain protein SCAP <xref ref-type="bibr" rid="pbio.1000181-Nohturfft1">&#x0005b;20&#x0005d;</xref>. The ER-resident proteins INSIG-1 <xref ref-type="bibr" rid="pbio.1000181-Yang1">&#x0005b;21&#x0005d;</xref> and INSIG-2 <xref ref-type="bibr" rid="pbio.1000181-Yabe1">&#x0005b;22&#x0005d;</xref> are responsible for the sterol-dependent retention of the SCAP-SREBP complex in the ER. SCAP and INSIG-2 are cholesterol and oxysterol sensors, respectively, and can both initiate formation of the SCAP-SREBP-INSIG ternary complex depending on sterol availability <xref ref-type="bibr" rid="pbio.1000181-Radhakrishnan1">&#x0005b;23&#x0005d;</xref>. At low sterol concentrations, the SCAP-SREBP complex is released from INSIG proteins and transported to Golgi vesicles, where the N-terminal SREBP moiety is cleaved. The processed SREBP protein then translocates to the nucleus and activates the transcription of genes encoding enzymes involved in fatty acid and cholesterol synthesis <xref ref-type="bibr" rid="pbio.1000181-Goldstein1">&#x0005b;24&#x0005d;</xref>.</p><p>Cytochrome P450 7&#x003b1;-hydroxylase (CYP7A1) is the rate-limiting enzyme in bile acid synthesis. <italic>Cyp7a1</italic> transcription is governed by many transcription factors, notably by several nuclear receptors <xref ref-type="bibr" rid="pbio.1000181-Moore1">&#x0005b;25&#x0005d;</xref>,<xref ref-type="bibr" rid="pbio.1000181-Russell1">&#x0005b;26&#x0005d;</xref>. For example, the two nuclear receptors Liver-X-Receptor (LXR) and Farnesoid-X-Receptor (FXR) regulate <italic>Cyp7a1</italic> expression depending on the availability of their ligands, which are themselves derivatives of cholesterol metabolism. LXR binds oxysterols (whose levels parallel those of cholesterol) and activates <italic>Cyp7a1</italic> transcription <xref ref-type="bibr" rid="pbio.1000181-Janowski1">&#x0005b;27&#x0005d;</xref>,<xref ref-type="bibr" rid="pbio.1000181-Peet1">&#x0005b;28&#x0005d;</xref>, whereas FXR binds bile acids and represses <italic>Cyp7a1</italic> transcription <xref ref-type="bibr" rid="pbio.1000181-Inagaki1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pbio.1000181-Sinal1">&#x0005b;31&#x0005d;</xref>. In addition, <italic>Cyp7a1</italic> expression has long been known to oscillate during the day, but the transcription factors implicated in this circadian transcription remained controversial.</p><p>Here we show that the orphan nuclear receptor REV-ERB&#x003b1; is a key player in the circadian regulation of cholesterol and bile acid synthesis by influencing rhythmic SREBP activity and <italic>Cyp7a1</italic> expression. Recently, Duez et al. <xref ref-type="bibr" rid="pbio.1000181-Duez1">&#x0005b;32&#x0005d;</xref> have reported that REV-ERB&#x003b1;-deficient mice have a low bile acid phenotype. Although our study is in keeping with this observation, on the basis of our genetic loss-of-function and gain-of-function studies we propose different molecular pathways accounting for the bile acid phenotype.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Identification of Putative REV-ERB&#x003b1; Target Genes by Affymetrix Microarray Analysis</title><p>To gain insight into the physiological functions of REV-ERB&#x003b1;, we identified REV-ERB&#x003b1; target genes in a genome-wide manner, using Affymetrix microarray hybridization analysis of liver RNA from <italic>Rev-erb</italic>&#x003b1; knock-out (Rev-KO) and wild-type (WT) animals humanely killed at ZT12 (ZT, Zeitgeber time; ZT0, lights on; ZT12: lights off). At this time point the differences in the expression of direct REV-ERB&#x003b1; target genes can be expected to be maximal in Rev-KO versus control animals (see <xref ref-type="bibr" rid="pbio.1000181-Preitner1">&#x0005b;8&#x0005d;</xref> and <xref ref-type="supplementary-material" rid="pbio.1000181.s001">Figure S1</xref>). Because REV-ERB&#x003b1; acts as a transcriptional repressor, transcripts specified by direct target genes should be overrepresented in the Rev-KO animals. Transgenic mice that overexpress hepatic REV-ERB&#x003b1; throughout the day <xref ref-type="bibr" rid="pbio.1000181-Kornmann1">&#x0005b;11&#x0005d;</xref> were also examined. In these animals, referred to as TgRev, direct REV-ERB&#x003b1; target genes should be expressed at low levels irrespective of the time of day. Accordingly, indirect target genes with reduced expression in Rev-KO mice should display constant high levels in TgRev animals. The differential expression of genes in the livers of WT, Rev-KO, and TgRev mice is shown in the genome-wide transcriptome profiling experiments displayed in <xref ref-type="fig" rid="pbio-1000181-g001">Figure 1A</xref> (see lists in <xref ref-type="supplementary-material" rid="pbio.1000181.s012">Table S1</xref> and <xref ref-type="supplementary-material" rid="pbio.1000181.s013">S2</xref>). As expected, most genes found to be up- and down-regulated in Rev-KO animals were down- and up-regulated, respectively, in TgRev mice (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1A</xref>, bracket I and III). Only a subset of genes did not follow this simple scenario and showed equal regulation in both Rev-KO and TgRev animals (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1A</xref>, bracket II and IV). Mechanistic models potentially accounting for such less intuitive accumulation profiles are depicted in <xref ref-type="supplementary-material" rid="pbio.1000181.s002">Figure S2</xref>.</p><fig id="pbio-1000181-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000181.g001</object-id><label>Figure 1</label><caption><title>REV-ERB&#x003b1; controls the temporal nuclear accumulation of SREBP and the transcription of SREBP target genes.</title><p>(A) Affymetrix-microarray analysis of liver RNA from mice of various genotypes. The heat map displays transcripts with differential accumulation in WT, Rev-KO, and TgRev mice. Differentially expressed transcripts of mice with different genotypes are clustered into four classes: class I: Rev-KO&#x0003e;WT&#x02265;TgRev; class II: Rev-KO&#x0003e;WT&#x0003c;TgRev; class III: Rev-KO&#x0003c;WT&#x02264;TgRev; class IV: Rev-KO&#x0003c;WT&#x0003e;TgRev (see also <xref ref-type="supplementary-material" rid="pbio.1000181.s002">Figure S2</xref>). (B) Temporal accumulation of SREBP1c in liver nuclear extract. (C) Temporal expression of transcripts from selected SREBP1c genes. (D) Temporal expression of transcripts from selected SREBP2 target genes. (E) Temporal expression of <italic>Insig2</italic> transcripts. The data displayed in (C&#x02013;E) were obtained by quantitative (Q) RT-PCR experiments on whole-cell liver RNA from WT, Rev-KO, and TgRev animals. The data represent the mean&#x000b1;SEM (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;4&#x02013;6).</p></caption><graphic xlink:href="pbio.1000181.g001"/></fig><p>REV-ERB&#x003b1; oscillates with a sharp expression peak in WT animals. We thus expected that most of the 76 genes (represented by 97 probe sets) that we identified as up-regulated in Rev-KO animals at ZT12 (<xref ref-type="supplementary-material" rid="pbio.1000181.s012">Table S1</xref>) would show circadian mRNA accumulation profiles in WT animals. For the 60 genes (represented by 81 probe sets) down-regulated in Rev-KO (<xref ref-type="supplementary-material" rid="pbio.1000181.s013">Table S2</xref>) this is not necessarily expected as they probably represent indirect REV-ERB&#x003b1; target genes. So far REV-ERB&#x003b1; has only been described as a transcriptional repressor. Obviously, it cannot be excluded that REV-ERB&#x003b1; might also function as an activator on certain target genes, for example by recruiting co-activators. Indeed, recruitment of both co-activators and co-repressors has been reported for the related nuclear receptor Retinoic acid receptor-related Orphan Receptor &#x003b1; (ROR&#x003b1;) <xref ref-type="bibr" rid="pbio.1000181-Harding1">&#x0005b;33&#x0005d;</xref>. We thus extracted the circadian accumulation profiles of the identified genes from a comprehensive study of genome-wide circadian hepatic gene expression at a 1-h resolution that was recently performed by the Hogenesch laboratory <xref ref-type="bibr" rid="pbio.1000181-Hughes1">&#x0005b;10&#x0005d;</xref> (see also Gene Expression Omnibus GSE11923 &#x0005b;<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo">http://www.ncbi.nlm.nih.gov/geo</ext-link>&#x0005d; and <ext-link ext-link-type="uri" xlink:href="http://bioinf.itmat.upenn.edu/circa">http://bioinf.itmat.upenn.edu/circa</ext-link>). Using stringent algorithms, around 1&#x00025; of the liver transcriptome was circadian in this analysis, whereas 54&#x00025; (41 transcripts) of the up-regulated and 43&#x00025; (26 transcripts) of the down-regulated fractions identified in our microarray analysis corresponded to circadian genes (<xref ref-type="supplementary-material" rid="pbio.1000181.s003">Figure S3</xref>). This result confirms that REV-ERB&#x003b1; is predominantly a regulator of circadian gene expression. The circadian phases of most of the up-regulated transcripts corresponded to that expected for direct REV-ERB&#x003b1; targets. The phases of the down-regulated transcripts were less uniform, possibly reflecting several indirect mechanisms.</p></sec><sec id="s2b"><title>SREBP Pathways Are Impaired in <italic>Rev-erb</italic>&#x003b1; Null Mice</title><p>Analysis of the microarray data showed that <italic>Rev-erb</italic>&#x003b1; disruption led to the misregulation of several genes involved in lipid metabolism. In particular, known target genes of the cholesterol-sensing transcription factor SREBP <xref ref-type="bibr" rid="pbio.1000181-Horton1">&#x0005b;34&#x0005d;</xref> were expressed at lower levels in Rev-KO animals (<xref ref-type="supplementary-material" rid="pbio.1000181.s013">Table S2</xref>). This suggested that the INSIG-SCAP-SREBP pathway was temporally misregulated. To examine this conjecture, we assessed the nuclear accumulation of SREBP1c in liver at 4-h intervals around the clock. In WT animals, nuclear SREBP1c protein was highly abundant at ZT12, but barely detectable at ZT0 and ZT4 (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1B</xref>). In Rev-KO animals, however, the accumulation of SREBP1c in the nucleus was shifted by 8 h (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1B</xref>). This phase-shifted nuclear SREBP1c protein accumulation in Rev-KO mice correlated with the phase-shifted expression of SREBP1c target genes, such as <italic>Fas</italic>, <italic>Elovl6</italic>, <italic>Fads2</italic>, <italic>Insig1</italic>, or <italic>Srebp1c</italic> itself (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1C</xref>, left panel). In TgRev mice, these genes were up-regulated at ZT0 and virtually unchanged at ZT12, with the exception of <italic>Fads2</italic> which was up-regulated at both time points (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1C</xref>). These findings substantiated the hypothesis that REV-ERB&#x003b1; controlled the temporal expression of SREBP1c target genes. The altered expression of <italic>Hmgcr</italic>, <italic>Low density lipoprotein receptor (Ldlr)</italic>, <italic>and Acetoacetyl-CoA synthetase (Aacs)</italic> in Rev-KO and TgRev animals suggested that the activity of SREBP2 was affected in these animals as well (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1D</xref>), in spite of the apparently normal <italic>Srebp2</italic> mRNA accumulation (<xref ref-type="supplementary-material" rid="pbio.1000181.s004">Figure S4A</xref>).</p><p>The altered nuclear accumulation of SREBP1c in livers of Rev-KO animals could have been due to a misregulation of its mRNA (and consequently protein) expression (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1C</xref>) and/or a delay in the processing and transport of SREBP1c to the nucleus. To investigate the latter possibility, we analyzed whether in Rev-KO mice there were any peculiarities to the SREBP processing machinery that would explain the delay in nuclear SREBP1c accumulation. Whereas <italic>Insig2a</italic> mRNA (coding for the major INSIG isoform in liver) showed a 7-fold circadian amplitude in WT livers, it was indeed expressed at constantly high and low levels in Rev-KO and TgRev mice, respectively (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1E</xref>). This suggested that <italic>Insig2a</italic> was a bona fide REV-ERB&#x003b1; target gene. We were unfortunately unable to examine whether corresponding changes also exist for INSIG2a on the protein level, since the two commercial anti-INSIG2a antibodies we purchased did not yield satisfactory results in immunoblot experiments. However, since INSIG2a is known to be a short-lived protein <xref ref-type="bibr" rid="pbio.1000181-Hegarty1">&#x0005b;35&#x0005d;</xref>, the oscillation of <italic>Insig2a</italic> mRNA very likely also translated to the rhythmic accumulation of INSIG2a protein in ER membranes. The expression of <italic>Scap</italic> mRNA (<xref ref-type="supplementary-material" rid="pbio.1000181.s004">Figure S4B</xref>) and the non-circadian minor <italic>Insig2b</italic> isoform (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1E</xref>) were not affected in Rev-KO mice.</p></sec><sec id="s2c"><title>REV-ERB&#x003b1; Regulates SREBP1c Target Genes Independently of the Feeding Regimen</title><p>As shown above, REV-ERB&#x003b1; controlled the nuclear accumulation of SREBPs and, thus, the expression of SREBP targets. However, it has also been shown that these processes are regulated by fasting&#x02013;feeding <xref ref-type="bibr" rid="pbio.1000181-Horton2">&#x0005b;36&#x0005d;</xref>, fatty acids <xref ref-type="bibr" rid="pbio.1000181-Ou1">&#x0005b;37&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pbio.1000181-Worgall1">&#x0005b;39&#x0005d;</xref>, and insulin <xref ref-type="bibr" rid="pbio.1000181-Shimomura1">&#x0005b;40&#x0005d;</xref>. Therefore, we wished to determine if the temporal misregulation of the SREBP pathway in Rev-KO mice merely reflected altered feeding rhythms and/or differences in plasma insulin. To this end, we recorded the time of food consumption in WT and Rev-KO animals by an infrared detection system; there were no major differences between the genotypes (<xref ref-type="fig" rid="pbio-1000181-g002">Figure 2A</xref>).</p><fig id="pbio-1000181-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000181.g002</object-id><label>Figure 2</label><caption><title>Fasting&#x02013;feeding regulation of SREBP targeted genes in Rev-KO mice.</title><p>(A) Feeding activity of three Rev-KO and WT mice as measured by an infrared detection system. (B) Mice that were either fasted for 24 h or (C) fed a high carbohydrate&#x02013;no fat diet for 18 d were humanely killed at ZT12, and the accumulation of selected mRNAs was measured in WT and Rev-KO (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;4 per each data point) using Q-RT PCR. (D) Insulin measurement from blood samples collected at ZT4, ZT12, and ZT16 (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;5 per each data point). (B&#x02013;D) data represent the mean&#x000b1;SEM.</p></caption><graphic xlink:href="pbio.1000181.g002"/></fig><p>We then fasted WT and Rev-KO mice for 24 h and measured the expression of selected SREBP target genes that we had found to be regulated in Rev-KO mice fed ad libitum at ZT12 (see <xref ref-type="fig" rid="pbio-1000181-g001">Figure 1C</xref>). As shown in <xref ref-type="fig" rid="pbio-1000181-g002">Figure 2B</xref>, fasting-induced repression of SREBP target genes such as <italic>Srebp1c</italic>, <italic>Fas</italic>, <italic>Elovl6</italic>, and <italic>Aacs</italic>, also occurred in the Rev-KO background. Also the fasting-induced up-regulation of <italic>Insig2a</italic><xref ref-type="bibr" rid="pbio.1000181-Yabe2">&#x0005b;41&#x0005d;</xref> reached similar expression levels in Rev-KO and control animals (<xref ref-type="fig" rid="pbio-1000181-g002">Figure 2B</xref>). The fold-up-regulation was obviously less dramatic in the Rev-KO because basal expression levels in the fed state were already 10-fold higher than in control animals.</p><p>We next fed mice with a high carbohydrate&#x02013;no fat diet that is known to induce the expression of lipogenic SREBP1c target genes such as <italic>Srebp1c</italic>, <italic>Fas</italic>, and <italic>Elovl6</italic>. Again, we measured the effects at ZT12 in Rev-KO and control mice, and found that diet-dependent regulation was independent of the genotype (<xref ref-type="fig" rid="pbio-1000181-g002">Figure 2C</xref>). In addition, we did not notice any differences in plasma insulin concentrations between the genotypes at ZT12 (when SREBP target genes are differentially regulated in WT and Rev-KO mice), at ZT4 (the beginning of the day phase), or at ZT16 (the beginning of the night phase) (<xref ref-type="fig" rid="pbio-1000181-g002">Figure 2D</xref>).</p><p>These findings suggest that the regulation of the SREBP pathway is governed by at least two independent processes. In addition to its regulation by fasting and feeding that has been described before, the circadian clock, through rhythmic REV-ERB&#x003b1; accumulation, regulates the SREBP pathway independently of the feeding regimen.</p></sec><sec id="s2d"><title>REV-ERB&#x003b1; Controls Temporal Lipid Accumulation in Blood and Liver</title><p>We wished to determine whether the temporal misregulation of SREBP1c also translated to corresponding alterations in the physiology of Rev-KO mice. SREBP1c target genes are implicated in the control of triglyceride synthesis in vivo, and Rev-KO mice indeed showed an altered accumulation of hepatic triglycerides (<xref ref-type="fig" rid="pbio-1000181-g003">Figure 3A</xref>). Moreover, AACS and HMGCR are key enzymes in cholesterol synthesis, and LDLR is responsible for the uptake of low-density lipoprotein (LDL)-cholesterol from the blood. We hence measured the hepatic cholesterol and the plasma LDL-cholesterol in Rev-KO and WT animals. As shown in <xref ref-type="fig" rid="pbio-1000181-g003">Figure 3B</xref>, Rev-KO animals had only a modest (albeit statistically significant) decrease in hepatic cholesterol at ZT12. By contrast, plasma LDL-cholesterol levels were highly increased in Rev-KO (<xref ref-type="fig" rid="pbio-1000181-g003">Figure 3C</xref>), possibly because of a defective LDL-cholesterol uptake by the LDL-receptor (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1D</xref>). We also noticed that HDL-cholesterol concentrations were augmented in the plasma of Rev-KO animals specifically at ZT12 (<xref ref-type="fig" rid="pbio-1000181-g003">Figure 3D and 3E</xref>). Conceivably, increased HDL-cholesterol levels in Rev-KO mice may have been caused by down- and up-regulation of the genes encoding endothelial lipase and apolipoprotein A1 (APOA1), respectively (<xref ref-type="supplementary-material" rid="pbio.1000181.s005">Figure S5A and S5B</xref>). APOA1 is the major lipoprotein in HDL particles <xref ref-type="bibr" rid="pbio.1000181-Cohen1">&#x0005b;42&#x0005d;</xref>, and endothelial lipase is an enzyme that catabolizes HDL-cholesterol <xref ref-type="bibr" rid="pbio.1000181-Jin1">&#x0005b;43&#x0005d;</xref>. However, in contrast to what had been reported previously <xref ref-type="bibr" rid="pbio.1000181-Raspe1">&#x0005b;44&#x0005d;</xref>, we did not notice changes in plasma-VLDL between both genotypes, and <italic>ApocIII</italic> mRNA expression in liver was not altered in our Rev-KO or TgRev mouse models (<xref ref-type="supplementary-material" rid="pbio.1000181.s005">Figure S5C</xref>).</p><fig id="pbio-1000181-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000181.g003</object-id><label>Figure 3</label><caption><title>Accumulation of cholesterol and triglycerides in liver and plasma of WT and Rev-KO mice.</title><p>(A) Total hepatic triglycerides and (B) cholesterol in WT mice (ZT12 <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;8, ZT20 <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;6) and Rev-KO mice (ZT12 <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;10, ZT20 <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;4). (C) Plasma LDL-cholesterol and (D) HDL-cholesterol in WT and Rev-KO (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;6 per each data point). (E) Plasma samples from animals humanely killed at ZT12 and ZT20 were pooled (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;6) and lipoproteins separated by fast protein liquid chromatography (FPLC). (A&#x02013;D) data represent the mean&#x000b1;SEM. <italic>p</italic>-Values: &#x0002a;, &#x0003c;0.05; &#x0002a;&#x0002a;, &#x0003c;0.005.</p></caption><graphic xlink:href="pbio.1000181.g003"/></fig><p>In summary, the misregulation of key enzymes involved in cholesterol metabolism in the livers of Rev-KO mice correlate well with the cholesterol phenotype of these animals. We nevertheless want to point out that extra-hepatic tissues may also have contributed to the phenotype (see <xref ref-type="sec" rid="s3">Discussion</xref>).</p></sec><sec id="s2e"><title><italic>Rev-erb&#x003b1;</italic> Knock-Out Mice Display Decreased Bile Acid Accumulation</title><p><italic>Cyp7a1</italic> expression has long been known to be circadian <xref ref-type="bibr" rid="pbio.1000181-Gielen1">&#x0005b;15&#x0005d;</xref>, and feeding&#x02013;fasting rhythms cannot fully account for the daily oscillations in bile acid synthesis <xref ref-type="bibr" rid="pbio.1000181-Duane2">&#x0005b;45&#x0005d;</xref>. Thus, the circadian clock probably contributes to cyclic <italic>Cyp7a1</italic> expression directly, thereby enabling the anticipation of the need for bile acids. As shown in <xref ref-type="fig" rid="pbio-1000181-g004">Figure 4A</xref>, both phase and magnitude of <italic>Cyp7a1</italic> expression were severely altered in Rev-KO mice. Moreover, <italic>Cyp7a1</italic> mRNA was constitutively high in TgRev mice (<xref ref-type="fig" rid="pbio-1000181-g004">Figure 4B</xref>). In Rev-KO animals, the amount of <italic>Cyp7a1</italic> mRNA, integrated over a day, only represented around 60&#x00025; of the level seen in the WT animals. To investigate whether the 40&#x00025; decrease has a consequence for bile acid metabolism, we determined the bile acid content in the gallbladder of Rev-KO animals and found a clear decrease in the most abundant primary and secondary bile acids cholate and deoxycholate (<xref ref-type="fig" rid="pbio-1000181-g004">Figure 4C</xref>). Furthermore, we also noted a general tendency for other bile acid species to accumulate to lower levels in the gallbladders of Rev-KO as compared to control animals (<xref ref-type="fig" rid="pbio-1000181-g004">Figure 4C</xref>).</p><fig id="pbio-1000181-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000181.g004</object-id><label>Figure 4</label><caption><title>REV-ERB&#x003b1; controls <italic>Cyp7a1</italic> transcription and bile acid accumulation.</title><p>(A) Temporal <italic>Cyp7a1</italic> mRNA accumulation in the livers of WT, Rev-KO, and (B) TgRev mice. The data represent the mean&#x000b1;SEM (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;4&#x02013;6). (C) Primary and secondary bile acid levels in gallbladders from WT and Rev-KO mice. Data represent the mean&#x000b1;SEM (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;6). <italic>p</italic>-Values: &#x0002a;, &#x0003c;0.05; &#x0002a;&#x0002a;, &#x0003c;0.005.</p></caption><graphic xlink:href="pbio.1000181.g004"/></fig></sec><sec id="s2f"><title>REV-ERB&#x003b1; Represses <italic>Cyp7a1</italic> Transcription through an Indirect Mechanism</title><p>Although it has been known for more than 30 years that <italic>Cyp7a1</italic> is expressed in a circadian fashion, the transcription factors responsible for this regulation are still subject to controversy. Our observation that diurnal <italic>Cyp7a1</italic> was dampened in Rev-KO mice and constitutively high in TgRev mice strongly indicated that <italic>Cyp7a1</italic> expression was linked to the circadian oscillator by REV-ERB&#x003b1;. Since REV-ERB&#x003b1; operates as a transcriptional repressor, the underlying mechanism was most likely indirect, and could have been caused by the down-regulation of a repressor that acts on the <italic>Cyp7a1</italic> gene. Our transcriptome profiling studies revealed the basic leucine zipper protein E4BP4/NFIL3 as a plausible candidate for such a repressor (<xref ref-type="supplementary-material" rid="pbio.1000181.s012">Table S1</xref>). As expected for a direct REV-ERB&#x003b1; target gene, <italic>E4bp4/Nfil3</italic> mRNA accumulation oscillated with the expected phase in WT mice (<xref ref-type="supplementary-material" rid="pbio.1000181.s006">Figure S6A</xref>), and was constitutively high and low in Rev-KO mice and TgRev mice, respectively (<xref ref-type="supplementary-material" rid="pbio.1000181.s006">Figure S6A and S6B</xref>). Temporal E4BP4/NFIL3 protein accumulation was found to be altered accordingly in WT and Rev-KO mice (<xref ref-type="supplementary-material" rid="pbio.1000181.s006">Figure S6C</xref>). Since E4BP4/NFIL3 has been shown to repress transcription through the D-element consensus sequence <named-content content-type="gene">5&#x02032;-RTTAGTAAY-3&#x02032;</named-content> (<xref ref-type="supplementary-material" rid="pbio.1000181.s006">Figure S6E</xref>) <xref ref-type="bibr" rid="pbio.1000181-Cowell1">&#x0005b;46&#x0005d;</xref>, a sequence also bound by the three PAR bZip transcription factors DBP, HLF, and TEF, it was tempting to speculate that the E4BP4/NFIL3 repressor and PAR bZip activators could have antagonistic effects on <italic>Cyp7a1</italic> transcription. In cotransfection experiments, DBP <xref ref-type="bibr" rid="pbio.1000181-Lavery1">&#x0005b;47&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pbio.1000181-Noshiro1">&#x0005b;49&#x0005d;</xref> and E4BP4/NFIL3 (<xref ref-type="supplementary-material" rid="pbio.1000181.s006">Figure S6D</xref>) indeed activated and repressed, respectively, transcription from the <italic>Cyp7a1</italic> promoter in a dose- and D-element-dependent manner. However, the implication of PAR bZip proteins or E4BP4 in circadian <italic>Cyp7a1</italic> regulation did not withstand scrutiny by loss-of-function experiments. As shown in <xref ref-type="fig" rid="pbio-1000181-g005">Figure 5A</xref>, <italic>Dbp/Tef/Hlf</italic> triple knock-out (TKO) mice still exhibited circadian <italic>Cyp7a1</italic> accumulation levels similar to those of WT animals (<xref ref-type="fig" rid="pbio-1000181-g005">Figure 5A</xref>). If E4BP4/NFIL3 directly repressed <italic>Cyp7a1</italic> transcription, <italic>Cyp7a1</italic> mRNA should accumulate to higher levels in <italic>E4bp4/Nfil3</italic>-KO mice at time ZT0, when <italic>Cyp7a1</italic> expression is low and E4BP4/NFIL3 protein highly abundant (<xref ref-type="fig" rid="pbio-1000181-g004">Figures 4A</xref> and <xref ref-type="supplementary-material" rid="pbio.1000181.s006">S6C</xref>). However, we found that <italic>Cyp7a1</italic> mRNA accumulated to similar levels at ZT0 and was dampened at ZT12 in <italic>E4bp4/Nfil3</italic>-deficient animals (<xref ref-type="fig" rid="pbio-1000181-g005">Figure 5B</xref>). These in vivo data argue against a putative role of E4BP4/NFIL3 as a direct <italic>Cyp7a1</italic> repressor. An indirect role of E4BP4/NFIL3 in regulating <italic>Cyp7a1</italic> appears to exist nevertheless, as judged by the down-regulation in the <italic>E4bp4/Nfil3</italic>-KO at ZT12 (a time point when E4BP4/NFIL3 is barely expressed; see <xref ref-type="supplementary-material" rid="pbio.1000181.s006">Figure S6C</xref>).</p><fig id="pbio-1000181-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000181.g005</object-id><label>Figure 5</label><caption><title>LXR participates in the circadian transcription of <italic>Cyp7a1</italic>.</title><p>Temporal <italic>Cyp7a1</italic> mRNA accumulation was measured in the livers of (A) <italic>Dbp/Tef/Hlf</italic> triple knock-out mice (B) <italic>E4bp4/Nfil3</italic> knock-out mice and (C) <italic>LXR</italic>&#x003b1;/&#x003b2; double knock-out animals. Data represent the mean&#x000b1;SEM (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;4).</p></caption><graphic xlink:href="pbio.1000181.g005"/></fig><p>It is known that in rodents changes in CYP7A1 activity parallel those of HMGCR activity, the enzyme that catalyzes the rate-limiting step in de novo cholesterol synthesis <xref ref-type="bibr" rid="pbio.1000181-Takeuchi1">&#x0005b;50&#x0005d;</xref>. The specific inhibition of HMGCR by compounds such as lovastatin results in decreased <italic>Cyp7a1</italic> mRNA accumulation <xref ref-type="bibr" rid="pbio.1000181-Jones1">&#x0005b;51&#x0005d;</xref>,<xref ref-type="bibr" rid="pbio.1000181-Pandak1">&#x0005b;52&#x0005d;</xref>. This decrease is prevented if mice receive the HMGCR inhibitor together with an infusion of mevalonate, the product of the reaction catalysed by HMGCR <xref ref-type="bibr" rid="pbio.1000181-Jones1">&#x0005b;51&#x0005d;</xref>,<xref ref-type="bibr" rid="pbio.1000181-Pandak1">&#x0005b;52&#x0005d;</xref>. In addition, inhibition of the last step in cholesterol synthesis by the compound AY9944 also decreases <italic>Cyp7a1</italic> expression <xref ref-type="bibr" rid="pbio.1000181-Pandak2">&#x0005b;53&#x0005d;</xref>. Thus circadian endogenous cholesterol synthesis <xref ref-type="bibr" rid="pbio.1000181-Edwards1">&#x0005b;17&#x0005d;</xref>,<xref ref-type="bibr" rid="pbio.1000181-Jurevics1">&#x0005b;54&#x0005d;</xref> seems to be linked to the regulation of the <italic>Cyp7a1</italic> transcription.</p><p>In Rev-KO and TgRev mice the down- and up-regulation of <italic>Hmgcr</italic> expression observed at ZT12 and ZT0, respectively (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1D</xref>), can be expected to engender corresponding changes in oxysterol production <xref ref-type="bibr" rid="pbio.1000181-DeBoseBoyd1">&#x0005b;55&#x0005d;</xref>. This, in turn, might have an impact on <italic>Cyp7a1</italic> transcription by LXR, which is known to be regulated by oxysterol availability <xref ref-type="bibr" rid="pbio.1000181-Wong1">&#x0005b;56&#x0005d;</xref>. It is thus conceivable, if not likely, that this pathway can impart on circadian <italic>Cyp7a1</italic> transcription via the activation of LXR receptors in spite of unchanged <italic>Lxr</italic>&#x003b1; and <italic>Lxr</italic>&#x003b2; mRNA levels in Rev-KO mice (<xref ref-type="fig" rid="pbio-1000181-g004">Figure 4SC</xref>). To test if LXRs could be at least in part responsible for circadian <italic>Cyp7a1</italic> transcription, we measured <italic>Cyp7a1</italic> transcript levels in <italic>Lxr</italic>&#x003b1;/<italic>Lxr</italic>&#x003b2; double knock-out mice (LXR&#x003b1;/&#x003b2;) at ZT0 and ZT12. As shown in <xref ref-type="fig" rid="pbio-1000181-g005">Figure 5C</xref>, control mice showed a 4-fold amplitude in <italic>Cyp7a1</italic> mRNA levels between ZT0 and ZT12, which was absent in LXR&#x003b1;/&#x003b2;-KO mice. This effect was not due to changes in <italic>Rev-erb</italic>&#x003b1; levels (unpublished data). Thus, a lack of LXR activation by oxysterols at ZT12 seemed to be the most likely scenario to explain the dampened <italic>Cyp7a1</italic> mRNA accumulation seen in Rev-KO mice. Similarly, the up-regulation of <italic>Hmgcr</italic> seen at ZT0 in TgRev animals could have led to increased levels of oxysterols and thus an increase of <italic>Cyp7a1</italic> transcription by LXR receptors.</p></sec></sec><sec id="s3"><title>Discussion</title><p>The genome-wide transcriptome analysis of livers from mice carrying <italic>Rev-erb</italic>&#x003b1; loss- and gain-of-function alleles has identified REV-ERB&#x003b1; as a circadian regulator of cholesterol/lipid and bile acid homeostasis.</p><p>Cholesterol is an essential molecule for membrane fluidity, and the synthesis of hormones and bile acids. Likewise, bile acids are required to emulsify absorbed lipids into micelles that are taken up by epithelial cells of the intestine and transported to the liver and other target organs. However, excessive cholesterol can lead to pathologies such as gallstone formation and atherosclerosis. At elevated concentrations bile acids are cytotoxic, and they can also function as proliferation signals <xref ref-type="bibr" rid="pbio.1000181-Huang1">&#x0005b;57&#x0005d;</xref>. To maintain the bile acid/cholesterol equilibrium, the gene encoding the rate-limiting enzyme of bile acid synthesis from cholesterol, <italic>Cyp7a1</italic>, is tightly regulated. Indeed, a myriad of transcription factors has been shown to act on its promoter (for review see <xref ref-type="bibr" rid="pbio.1000181-Moore1">&#x0005b;25&#x0005d;</xref>). While the regulatory processes are based on substrate and end-product sensing, <italic>Cyp7a1</italic> expression is also known to be subject to circadian control <xref ref-type="bibr" rid="pbio.1000181-Gielen1">&#x0005b;15&#x0005d;</xref>.</p><p>Our data suggest that the circadian clock component REV-ERB&#x003b1; participates in this process. Indeed, we found that REV-ERB&#x003b1; controls the timing of cyclic accumulation of SREBP in the nucleus, which in turn regulates the temporal expression of HMGCR. In Rev-KO mice, <italic>Hmgcr</italic> misregulation could engender a diminution of oxysterol production and compromise the LXR-oxysterol-mediated transcription of <italic>Cyp7a1</italic><xref ref-type="bibr" rid="pbio.1000181-Wong1">&#x0005b;56&#x0005d;</xref>. Our hypothesis is supported by the fact that drugs which inhibit HMGCR activity are known to decrease <italic>Cyp7a1</italic> transcription, and that circadian <italic>Cyp7a1</italic> expression is severely blunted in Lxr&#x003b1;/&#x003b2; knock-out mice (<xref ref-type="fig" rid="pbio-1000181-g005">Figure 5C</xref>). It will be interesting to directly determine hepatic oxysterol levels in order to support our conjecture that LXR isoforms drive circadian <italic>Cyp7a1</italic> transcription. Unfortunately, as pointed out by Schroepfer <xref ref-type="bibr" rid="pbio.1000181-Schroepfer1">&#x0005b;58&#x0005d;</xref>, the methods necessary for measuring oxysterols in a reproducible fashion are still challenging. In a recent study, Duez and coworkers <xref ref-type="bibr" rid="pbio.1000181-Duez1">&#x0005b;32&#x0005d;</xref> have postulated that REV-ERB&#x003b1; regulates <italic>Cyp7a1</italic> transcription by repressing the expression of both E4BP4/NFIL3 and small heterodimer partner (SHP). In our study, however, we did not observe a strong misregulation of <italic>Shp</italic> mRNA accumulation in Rev-KO mice and actually found higher levels in TgRev mice at both time points tested (<xref ref-type="supplementary-material" rid="pbio.1000181.s007">Figure S7</xref>). Several previous studies argue against a major role for SHP in <italic>Cyp7a1</italic> regulation as well. First, <italic>Cyp7a1</italic> expression is known to be only mildly up-regulated in livers of <italic>Shp</italic> knock-out mice <xref ref-type="bibr" rid="pbio.1000181-Kerr1">&#x0005b;59&#x0005d;</xref>. Moreover, the feedback repression of <italic>Cyp7a1</italic> by FXR agonists has been reported to persist in a mouse model carrying a hepatocyte-specific disruption of <italic>Fxr</italic> alleles, despite the lack of <italic>Shp</italic> induction <xref ref-type="bibr" rid="pbio.1000181-Kim1">&#x0005b;60&#x0005d;</xref>. Furthermore, the circadian phase of <italic>Shp</italic> expression does not correlate with that of other REV-ERB&#x003b1; target genes. <italic>Shp</italic> mRNA accumulation peaks at ZT8 in WT mice; REV-ERB&#x003b1; target genes are at their trough at this time-point. Hence, we do not consider REV-ERB&#x003b1;-controlled SHP expression a very likely mechanism accounting for circadian <italic>Cyp7a1</italic> expression.</p><p>Our genetic loss-of-function experiments did not support the role of E4BP4/NFIL3 in circadian <italic>Cyp7a1</italic> expression suggested previously by Duez et al. <xref ref-type="bibr" rid="pbio.1000181-Duez1">&#x0005b;32&#x0005d;</xref>. Although we observed a similar repressive activity of E4BP4/NFIL3 on the <italic>Cyp7a1</italic> promoter in co-transfection experiments (<xref ref-type="supplementary-material" rid="pbio.1000181.s006">Figure S6D</xref>; see also <xref ref-type="bibr" rid="pbio.1000181-Duez1">&#x0005b;32&#x0005d;</xref>), there was no up-regulation of <italic>Cyp7a1</italic> expression in the livers of <italic>E4bp4/Nfil3</italic> knock-out mice. Hence, we believe that E4BP4/NFIL3 only down-regulates <italic>Cyp7a1</italic> transcription when overexpressed at unphysiologically high levels. Gain-of-function studies, which are notoriously difficult to interpret, have also led to the suggestion that DBP serves as a circadian activator of <italic>Cyp7a1</italic> transcription <xref ref-type="bibr" rid="pbio.1000181-Lavery1">&#x0005b;47&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pbio.1000181-Noshiro1">&#x0005b;49&#x0005d;</xref>. Again, this result did not bear up against loss-of-function data in the corresponding knock-out mice (<xref ref-type="fig" rid="pbio-1000181-g005">Figure 5A</xref>). We thus believe that neither E4BP4/NFIL3 nor DBP (or its paralogs TEF and HLF) play significant roles as direct regulators of circadian <italic>Cyp7a1</italic> expression. Our loss-of-function data, rather, implicate the nuclear receptors LXR&#x003b1;/&#x003b2; in the circadian regulation of <italic>Cyp7a1</italic> transcription, but we are aware that the biochemical dissection of this network will require additional experiments.</p><p>The liver-specificity of the <italic>Rev-erb</italic>&#x003b1; transgene in the TgRev mice made it unlikely that the misregulation of <italic>Cyp7a1</italic> in the liver originated from a dysfunction outside of this organ. We nevertheless decided to analyze the expression of <italic>Fgf15</italic> in Rev-KO mice, as it is known that this hormone is intestinally produced to negatively feed back on <italic>Cyp7a1</italic> transcription <xref ref-type="bibr" rid="pbio.1000181-Inagaki1">&#x0005b;29&#x0005d;</xref>. In addition a recent publication showed that in humans, circulating FGF19 (the homologue of FGF15) has a diurnal variation <xref ref-type="bibr" rid="pbio.1000181-Lundasen1">&#x0005b;61&#x0005d;</xref>. We found <italic>Fgf15</italic> to be expressed at similar levels in the intestines of WT and Rev-KO mice (<xref ref-type="supplementary-material" rid="pbio.1000181.s008">Figure S8</xref>). Despite an induction of expression at ZT12, <italic>Fgf15</italic> mRNA levels did not display robust circadian oscillations.</p><p>The circadian utilization of cholesterol for bile acid synthesis must be counterbalanced by cholesterol synthesis and uptake in order to maintain stable cholesterol levels. In principle, the sterol-dependent processing and activation of the cholesterol-sensing transcription factor SREBP might be expected to suffice for this purpose. However, our study indicates that SREBP processing is also under circadian control exerted by REV-ERB&#x003b1;. Thus, REV-ERB&#x003b1; governs the rhythmic abundance of INSIG2, which in turn influences the diurnal translocation of SREBP to the nucleus where it transactivates its target genes. Interestingly, FXR has been previously shown to transactivate <italic>Insig2a</italic> expression at the beginning of the light phase <xref ref-type="bibr" rid="pbio.1000181-Hubbert1">&#x0005b;62&#x0005d;</xref> and therefore it would be interesting to test the contribution of this nuclear receptor in the circadian regulation of <italic>Insig2a</italic> transcription. Thus, FXR and REV-ERB&#x003b1;, by activating and repressing <italic>Insig2a</italic> transcription, respectively, could act antagonistically on the SREBP pathway.</p><p>We found that nuclear SREBP accumulation and target gene expression were misregulated in Rev-KO mice despite indistinguishable feeding rhythms, fasting responses, and insulin levels. This finding strongly suggests that REV-ERB&#x003b1; and the circadian clock impact the SREBP pathway by a more direct mechanism. At ZT12, when animals start to feed, REV-ERB&#x003b1; represses <italic>Insig2a</italic>, and SREBP strongly accumulates in the nucleus. Subsequently <italic>Hmgcr</italic> transcription is induced, and cholesterol synthesis will peak shortly thereafter, together with <italic>Cyp7a1</italic> transcription. Through this elaborate control of timing, the bile acid pool will be replenished in coordination with food uptake. Bile acids will thus be sufficiently available to emulsify dietary lipids.</p><p>In addition, our transcriptome analysis of Rev-KO mice points to a broader role for this nuclear receptor as a circadian regulator of lipid metabolism. REV-ERB&#x003b1; regulates genes such as <italic>Elovl3</italic>, <italic>Elovl5</italic>, <italic>Lipoprotein lipase</italic>, <italic>Fatty acid binding protein 5</italic>, <italic>Acyl-CoA thioesterase 3</italic>, or <italic>Phosphatidylcholine transfer protein</italic> (<xref ref-type="supplementary-material" rid="pbio.1000181.s009">Figure S9</xref>). Moreover, we have recently shown that REV-ERB&#x003b1; participates in the transcription of the liver-specific miRNA miR-122 <xref ref-type="bibr" rid="pbio.1000181-Gatfield1">&#x0005b;63&#x0005d;</xref>. This miRNA is known to function in lipid and cholesterol metabolism <xref ref-type="bibr" rid="pbio.1000181-Esau1">&#x0005b;64&#x0005d;</xref>,<xref ref-type="bibr" rid="pbio.1000181-Krutzfeldt1">&#x0005b;65&#x0005d;</xref>.</p><p>Finally, our in vivo studies do not support the view that REV-ERB&#x003b1; plays a key role in glucose homeostasis, a hypothesis recently proposed by work with HepG2 cells <xref ref-type="bibr" rid="pbio.1000181-Levi1">&#x0005b;66&#x0005d;</xref>. Although we did notice a mild hyperglycemia at ZT12 in Rev-KO mice (<xref ref-type="supplementary-material" rid="pbio.1000181.s010">Figure S10E</xref>), the circadian expression of <italic>Phosphoenol pyruvate carboxykinase</italic> (<italic>Pepck</italic>) was nearly unaltered, and that of <italic>Glucose 6-phosphatase</italic> (<italic>G6pase</italic>) was only moderately affected (<xref ref-type="supplementary-material" rid="pbio.1000181.s010">Figure S10A and S10</xref>B). Moreover, these genes were not significantly repressed by overexpressed REV-ERB&#x003b1; (B). In addition, the expression of <italic>Glucokinase</italic> (<italic>Gk</italic>) was not affected by <italic>Rev-erb</italic>&#x003b1; loss- and gain-of-function (<xref ref-type="supplementary-material" rid="pbio.1000181.s010">Figure S10C</xref>). Most importantly, no notable differences in blood glucose clearance were observed between WT and Rev-KO mice upon intraperitoneal glucose injection (<xref ref-type="supplementary-material" rid="pbio.1000181.s010">Figure S10D</xref>). Possible explanations for this discrepancy may lie in species-specific functions of REV-ERB&#x003b1; and/or the difficulty to extrapolate from in vitro or tissue culture studies to physiology in the animal.</p><p>In conclusion, the data presented in this study suggest that the circadian orphan nuclear receptor REV-ERB&#x003b1; modulates lipid and bile acid metabolism by affecting the SREBP pathway and the regulation of <italic>Cyp7a1</italic> transcription (<xref ref-type="fig" rid="pbio-1000181-g006">Figure 6</xref>). Our studies, together with work on the substrate-sensing nuclear receptors <xref ref-type="bibr" rid="pbio.1000181-Yang2">&#x0005b;67&#x0005d;</xref>,<xref ref-type="bibr" rid="pbio.1000181-Chawla1">&#x0005b;68&#x0005d;</xref>, exemplify how the circadian clock can cooperate with inducible regulatory mechanisms in the daily tuning of lipid and bile acid homeostasis.</p><fig id="pbio-1000181-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1000181.g006</object-id><label>Figure 6</label><caption><title>The role of REV-ERB&#x003b1; in circadian lipid and bile acid homeostasis.</title><p>The cartoon illustrates how REV-ERB&#x003b1; may modulate circadian lipid, cholesterol, and bile acid synthesis by controlling the accumulation of SREBP in the nucleus. In liver hepatocytes, REV-ERB&#x003b1; accumulates to maximal levels at ZT8&#x02013;ZT12 and represses <italic>Insig2</italic> transcription. Thereby, it promotes the proteolytic activation and nuclear accumulation of SREBP proteins. In turn, the circadian activation of SREBP transcription factors drives the cyclic transcription of <italic>Hmgcr</italic>, encoding the rate-limiting enzyme of cholesterol biosynthesis. As a consequence the levels of oxysterols, which serve as ligands for LXR, also oscillate during the day, and cyclically activated LXR then controls rhythmic <italic>Cyp7a1</italic> transcription.</p></caption><graphic xlink:href="pbio.1000181.g006"/></fig></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Animal Care and Treatment</title><p>All animal studies were conducted in accordance with the regulations of the veterinary office of the State of Geneva and Dutch and Austrian regulations according to criteria outlined in the Guide for the Care and Use of Laboratory Animals prepared by the National Academy of Sciences, as published by the National Institutes of Health. Rev-KO mice have been previously described <xref ref-type="bibr" rid="pbio.1000181-Preitner1">&#x0005b;8&#x0005d;</xref>. Transgenic mice that overexpress hepatic REV-ERB&#x003b1; contain two transgenes <xref ref-type="bibr" rid="pbio.1000181-Kornmann1">&#x0005b;11&#x0005d;</xref>. Briefly, the first transgene encodes an HA-epitope-tagged REV-ERB&#x003b1; cDNA controlled by a tetracycline responsive element and the second one expresses a hepatocyte-specific tetracycline-dependent transactivator. In the presence of doxycycline (Dox), transactivator binding is inhibited and thus the <italic>Rev-erb</italic>&#x003b1; transgene remains silent. Dox-fed mice or mice containing only one of the two transgenes were used as control animals. <italic>Lxr</italic>&#x003b1;/<italic>Lxr</italic>&#x003b2; double knock-out and <italic>Dbp/Tef/Hlf</italic> triple knock-out have been previously described <xref ref-type="bibr" rid="pbio.1000181-Gachon3">&#x0005b;69&#x0005d;</xref>,<xref ref-type="bibr" rid="pbio.1000181-Kalaany1">&#x0005b;70&#x0005d;</xref>. The <italic>E4bp4/Nfil3</italic> knock-out mice have been generated by the laboratory of Andrew Thomas Look (Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts). Briefly, exon 2 of the <italic>E4bp4/Nfil3</italic> gene that contains the full coding sequence has been replaced by a neomycin cassette (A.T. Look, personal communication). As expected, no <italic>E4bp4/Nfil3</italic> mRNA could be detected in these mice, see <xref ref-type="supplementary-material" rid="pbio.1000181.s011">Figure S11</xref>. Except for <xref ref-type="fig" rid="pbio-1000181-g002">Figure 2B and 2C</xref> where mice were fasted for 24 h or were fed a high carbohydrate&#x02013;no fat diet (Harlan Teklad TD03314), animals received a normal chow diet. Mice were maintained under standard animal housing conditions (12-h light/12-h dark cycle), with free access to food and water.</p></sec><sec id="s4b"><title>Affymetrix Oligonucleotide Microarray Hybridization</title><p>Whole-cell liver RNAs from 18 WT and 18 Rev-KO animals (3&#x02013;4 mo old) humanely killed at ZT12 were used. Three RNA pools of six mice per pool were assembled by mixing equal amounts of RNA. For liver-specific transgenic <italic>Rev-erb</italic>&#x003b1; mice, six animals each for Dox-treated and untreated mice were humanely killed at ZT12 and whole-cell liver RNA was extracted from each animal. Two RNA pools of three animals were assembled by mixing equal amounts of RNA. For Rev-KO, TgRev and WT control animals, 5 &#x000b5;g of pooled RNA were employed for the synthesis of biotinylated cRNA, and 8.75 &#x000b5;g of this cRNA were hybridized to Affymetrix Mouse Genome 430 2.0 array (according to the Affymetrix protocol). To identify differentially expressed transcripts, pairwise comparisons were carried out using Affymetrix GCOS 1.2 software. In the Rev-KO versus WT mice experiment, each of the three experimental samples was compared to each of the three reference samples, resulting in nine pairwise comparisons. This approach is based on the Mann-Whitney pairwise comparison test and allows the ranking of results by concordance, as well as the calculation of significance (<italic>p</italic>-value) for each identified change in gene expression <xref ref-type="bibr" rid="pbio.1000181-Hubbell1">&#x0005b;71&#x0005d;</xref>,<xref ref-type="bibr" rid="pbio.1000181-Liu1">&#x0005b;72&#x0005d;</xref>. Genes for which the concordance in the pairwise comparisons exceeded the imposed threshold of 77&#x00025; (seven out of nine comparisons) were considered to be statistically significant. In addition, we only selected transcripts whose accumulation had an average change of at least 1.5-fold. For these selected probe sets microarray data for the transgenic <italic>Rev-erb</italic>&#x003b1; mice was then extracted (<xref ref-type="fig" rid="pbio-1000181-g001">Figure 1A</xref>) from the study reported in Kornmann et al. <xref ref-type="bibr" rid="pbio.1000181-Kornmann1">&#x0005b;11&#x0005d;</xref>.</p></sec><sec id="s4c"><title>Quantitative Reverse Transcriptase-PCR Analysis</title><p>cDNA was synthesized from 1 &#x000b5;g of liver whole-cell RNA using random hexamers and Superscript II reverse transcriptase (RT) (Invitrogen) following the supplier's instructions. Five percent of this cDNA was PCR amplified (7900HT Sequence Detection Systems, Applied Biosystems) by using the Sybr Green master mix (Applied Biosystems), and raw threshold-cycle (Ct) values were calculated with SDS 2.0 software (Applied Biosystems). Mean values were calculated from triplicate PCR assays for each sample and normalized to those obtained for <italic>Cyclophillin</italic> and <italic>Eef1a1</italic> transcripts, which served as internal controls <xref ref-type="bibr" rid="pbio.1000181-Vandesompele1">&#x0005b;73&#x0005d;</xref>. For a list of primers used in this study, see <xref ref-type="supplementary-material" rid="pbio.1000181.s014">Table S3</xref>.</p></sec><sec id="s4d"><title>Western Blotting</title><p>Nuclear extracts were prepared by the NUN procedure as described previously <xref ref-type="bibr" rid="pbio.1000181-Lavery1">&#x0005b;47&#x0005d;</xref>, and Western blotting was performed according to standard protocols using a mouse anti-SREBP1 monoclonal antibody (BD Biosciences 557036).</p></sec><sec id="s4e"><title>Blood Chemistry</title><p>Blood samples were collected at <italic>Zeitgeber</italic> times 12 and 20 (ZT12 and ZT20) in lithium heparin containing tubes (BD Microtainer) and centrifuged for 10 min at 4,500 rpm. Plasma supernatants were kept frozen at &#x02212;20&#x000b0;C. The levels of HDL- and LDL-cholesterol were measured using a Roche-diagnostics Enzymatic kit for the Hitachi 902 robot according to the manufacturer's instruction. For Rev-KO mice and WT animals (humanely killed at ZT12 and 20) plasma samples were pooled (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;6) and lipoproteins separated by fast protein liquid chromatography (FPLC) on a Superose 6B 10/30 column (Amersham Bioscience). The level of insulin was measured using an ELISA kit (Mercodia 10-1150-01) according to the manufacturer's instruction, from blood samples collected at ZT4, ZT12, and ZT16.</p></sec><sec id="s4f"><title>Bile Analysis</title><p>Mice were anesthetized by intraperitoneal injection of Hypnorm (fentanyl/fluanisone 1 ml/kg) and diazepam (10 mg/kg). Bile was collected during 30 min by cannulation of the gallbladder, and total bile acids were measured enzymatically <xref ref-type="bibr" rid="pbio.1000181-Mashige1">&#x0005b;74&#x0005d;</xref>. Total gallbladder cholesterol was measured according to Kruth et al <xref ref-type="bibr" rid="pbio.1000181-Kruth1">&#x0005b;75&#x0005d;</xref>. For the determination of specific bile acid species, bile acids extracted from bile <xref ref-type="bibr" rid="pbio.1000181-Bligh1">&#x0005b;76&#x0005d;</xref> were analyzed by gas chromatography mass spectrometry (GC-MS).</p></sec><sec id="s4g"><title>Hepatic Cholesterol and Triglycerides</title><p>Livers were homogenized and lipids extracted as described by Bligh and Dyer <xref ref-type="bibr" rid="pbio.1000181-Bligh1">&#x0005b;76&#x0005d;</xref>. Hepatic triglyceride and cholesterol concentrations were measured using an enzymatic kit (Roche Molecular Biochemicals, Mannheim, Germany) according to the manufacturer's instruction.</p></sec><sec id="s4h"><title>Accession Numbers</title><p>The GenBank (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Genbank">http://www.ncbi.nlm.nih.gov/Genbank</ext-link>) accession numbers for the genes and gene products discussed in this paper are <italic>Aacs</italic> (NM_030210); <italic>Acot3</italic> (NM_134246); <italic>Apoa1</italic> (NM_009692); <italic>ApoCIII</italic> (NM_023114); <italic>Bmal1</italic> (NM_007489); <italic>Cyp7a1</italic> (NM_007824); <italic>Dbp</italic> (NM_016974); <italic>E4bp4/Nfil3</italic> (NM_017373); <italic>Elovl3</italic> (NM_007703); <italic>Elovl5</italic> (NM_134255); <italic>Elovl6</italic> (NM_130450); <italic>Fabp5</italic> (NM_010634); <italic>Fads2</italic> (NM_019699); <italic>Fas</italic> (NM_007988); <italic>Fgf15</italic> (NM_008003); <italic>G6pc</italic> (NM_008061); <italic>Glucokinase</italic> (NM_010292); <italic>Hlf</italic> (NM_172563); <italic>Hmgcr</italic> (NM_008255); <italic>Insig1</italic> (NM_153526); <italic>Insig2</italic> (NM_133748); <italic>Ldlr</italic> (NM_010700); <italic>Lipase endothelial</italic> (NM_010720); <italic>Lpl</italic> (NM_008509); <italic>Lxr&#x003b1;</italic> (NM_013839); <italic>Lxr</italic>&#x003b2; (NM_009473); <italic>Pctp</italic> (NM_008796); <italic>Pepck</italic> (NM_011044); <italic>Rev-erb</italic>&#x003b1; (NM_145434); <italic>Scap</italic> (NM_001001144); <italic>Shp</italic> (NM_011850); <italic>Srebp1</italic> (NM_011480); <italic>Srebp2</italic> (NM_033218); <italic>Tef</italic> (NM_017376).</p><p>The ArrayExpress repository (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/arrayexpress">http://www.ebi.ac.uk/arrayexpress</ext-link>) accession number for the microarray data is E-TABM-726.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pbio.1000181.s001"><label>Figure S1</label><caption><p><bold>Temporal expression of </bold><bold><italic>Rev-erb</italic></bold><bold>&#x003b1; and </bold><bold><italic>Bmal1</italic></bold><bold> mRNA in liver of WT and Rev-KO mice, as monitored by quantitative RT-PCR.</bold> mRNA levels were determined around the clock from pooled whole-cell RNAs (four to six animals per time point).</p><p>(0.45 MB EPS)</p></caption><media xlink:href="pbio.1000181.s001.eps" mimetype="application" mime-subtype="postscript"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s002"><label>Figure S2</label><caption><p><bold>Possible mechanisms accounting for the four major expression patterns identified in </bold><xref ref-type="fig" rid="pbio-1000181-g001"><bold>Figure 1A</bold></xref><bold>.</bold> In the left diagrams, target gene expression (<italic>y</italic>-axis) is schematically plotted against REV-ERB&#x003b1; concentration. The diagrams to the right depict possible protein-DNA and protein-protein interactions that might account for the observed expression patterns. Class I: The genes belonging to this class are likely to be direct REV-ERB&#x003b1; targets. Their expression is upregulated in the Rev-KO mice, and repressed equally or more efficiently in TgRev mice as compared to WT mice. Class II: These genes may also be direct REV-ERB&#x003b1; targets, but their transcription is less efficiently repressed in an excess of REV-ERB&#x003b1;. Conceivably, unsuccessful competition of promoter-bound REV-ERB&#x003b1; with free REV-ERB&#x003b1; (or REV-ERB&#x003b1; bound nonspecifically to other DNA sequences) for corepressor complexes may account for the derepression at high REV-ERB&#x003b1; concentrations. The competition of promoter-bound and unbound transcriptional regulators for rate-limiting cofactors was termed squelching by Gill and Ptashne <xref ref-type="bibr" rid="pbio.1000181-Gill1">&#x0005b;77&#x0005d;</xref>. Class III: The transcription of these genes is indirectly regulated by REV-ERB&#x003b1;, because of the down regulation of a repressor (i.e., E4BP4/NFIL3). Class IV: Indirect REV-ERB&#x003b1; target genes (see class III) whose repressor is encoded by a class II gene (i.e., squelched at high REV-ERB&#x003b1; concentrations). Obviously, many other, more complex mechanisms may also account for the expression patterns of class II and class IV transcripts.</p><p>(0.74 MB EPS)</p></caption><media xlink:href="pbio.1000181.s002.eps" mimetype="application" mime-subtype="postscript"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s003"><label>Figure S3</label><caption><p><bold>Analysis of circadian mRNA accumulation profiles of the genes found to be up- and down-regulated in Rev-KO mice.</bold> Temporal accumulation patterns of the 76 and 60 transcripts listed in <xref ref-type="supplementary-material" rid="pbio.1000181.s012">Table S1</xref> and <xref ref-type="supplementary-material" rid="pbio.1000181.s013">S2</xref> (represented by 97 and 81 probe sets, respectively) that were found to be &#x02265;1.5-fold up- and down-regulated in Rev-KO mice at ZT12. These profiles were retrieved from the Gene Expression Omnibus GSE11923 and <ext-link ext-link-type="uri" xlink:href="http://bioinf.itmat.upenn.edu/circa">http://bioinf.itmat.upenn.edu/circa</ext-link> database <xref ref-type="bibr" rid="pbio.1000181-Hughes1">&#x0005b;10&#x0005d;</xref>. This database contains the circadian analysis of the hepatic transcriptome at a 1-h resolution. (A) Phase distribution of the 454 probe sets found to be circadian in WT mice. (B) Phase distribution of the 56 and (C) 35 probe sets found to be up- or down-regulated in Rev-KO mice and circadian in WT animals (with an amplitude of &#x02265;2, see Kornmann et al. for details <xref ref-type="bibr" rid="pbio.1000181-Kornmann1">&#x0005b;11&#x0005d;</xref>). The up- and down-regulated probe sets in Rev-KO mice are enriched 55- and 43-fold, respectively, in circadian probe sets (<italic>p</italic>&#x0003c;10<sup>&#x02212;10</sup>).</p><p>(0.40 MB EPS)</p></caption><media xlink:href="pbio.1000181.s003.eps" mimetype="application" mime-subtype="postscript"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s004"><label>Figure S4</label><caption><p><bold>Temporal hepatic expression of transcripts specified by (A) </bold><bold><italic>Srebp2</italic></bold><bold>, (B) </bold><bold><italic>Scap</italic></bold><bold>, and (C) </bold><bold><italic>Lxr</italic></bold><bold>&#x003b1; and </bold><bold><italic>Lxr</italic></bold><bold>&#x003b2; in WT and Rev-KO mice, as monitored by quantitative RT-PCR.</bold> mRNA levels were determined around the clock from pooled whole-cell RNAs (four to six animals per time point).</p><p>(0.53 MB EPS)</p></caption><media xlink:href="pbio.1000181.s004.eps" mimetype="application" mime-subtype="postscript"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s005"><label>Figure S5</label><caption><p><bold>Temporal hepatic expression of transcripts specified by (A) </bold><bold><italic>Lipase endothelial</italic></bold><bold>, (B) </bold><bold><italic>Apoa1</italic></bold><bold>, (C) </bold><bold><italic>Apoc3</italic></bold><bold> in WT, Rev-KO, and TgRev mice.</bold> In the left panels mRNA levels were quantified as described in the legend to <xref ref-type="supplementary-material" rid="pbio.1000181.s004">Figure S4</xref>. The right histograms show mean values&#x000b1;standard error of the mean (SEM) obtained from individual animals at ZT0 and ZT12 (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;3 for WT mice, and <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;4 for TgRev mice).</p><p>(0.43 MB EPS)</p></caption><media xlink:href="pbio.1000181.s005.eps" mimetype="application" mime-subtype="postscript"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s006"><label>Figure S6</label><caption><p><bold>REV-ERB&#x003b1; controls the circadian expression of the E4bp4/Nfil3 repressor.</bold> Temporal <italic>E4bp4/Nfil3</italic> mRNA accumulation in the livers of (A) Rev-KO and (B) TgRev mice. (C) Immunoblot analysis of E4BP4/NFIL3 accumulation at ZT0, ZT4, ZT8, ZT12, ZT16, and ZT20 in livers of WT and Rev-KO mice. The same blot was probed with an antibody against the constitutively expressed splicing factor U2AF<sup>65</sup> (loading control). (D) Cotransfection of an E4BP4/NFIL3 expression vector with <italic>Cyp7a1</italic>-luciferase reporter genes harboring an intact D-element (black columns) or two mutated D-elements (mut1, white columns; mut2, grey columns). The sequences of intact D-elements and mutated D-elements are depicted in (E).</p><p>(1.75 MB EPS)</p></caption><media xlink:href="pbio.1000181.s006.eps" mimetype="application" mime-subtype="postscript"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s007"><label>Figure S7</label><caption><p><bold>Temporal hepatic expression of transcripts specified by the SHP in WT, Rev-KO, and TgRev mice.</bold> In the left panels mRNA levels were quantified as described in the legend to <xref ref-type="supplementary-material" rid="pbio.1000181.s004">Figure S4</xref>. The right histogram shows mean values&#x000b1;SEM obtained for individual animals at ZT0 and ZT12 (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;3 for WT mice, and <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;4 for TgRev mice).</p><p>(0.47 MB EPS)</p></caption><media xlink:href="pbio.1000181.s007.eps" mimetype="application" mime-subtype="postscript"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s008"><label>Figure S8</label><caption><p><bold>Temporal intestinal (Ileum) expression of transcripts specified by the fibroblast growth factor 15 in WT and Rev-KO, as monitored by quantitative RT-PCR. mRNA levels were determined around the clock.</bold> The data are represented as mean values&#x000b1;SEM (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;4 animals per time point).</p><p>(0.31 MB EPS)</p></caption><media xlink:href="pbio.1000181.s008.eps" mimetype="application" mime-subtype="postscript"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s009"><label>Figure S9</label><caption><p><bold>Expression of genes involved in hepatic lipid metabolism and transport in WT and Rev-KO mice.</bold> The temporal hepatic expression of transcripts was determined by Northern blot hybridization (<italic>Elovl3</italic> and <italic>Elovl5</italic>), or quantitative RT-PCR (<italic>Lpl</italic>, <italic>Fabp5</italic>, <italic>Pctp</italic>, <italic>Acot3</italic>) from pooled whole-cell RNAs from four to six animals per time point.</p><p>(2.83 MB EPS)</p></caption><media xlink:href="pbio.1000181.s009.eps" mimetype="application" mime-subtype="postscript"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s010"><label>Figure S10</label><caption><p><bold>REV-ERB&#x003b1; plays a minor role in glucose homeostasis.</bold> Temporal expression of (A) <italic>Pepck</italic>, (B) <italic>G6pc</italic>, and (C) <italic>Gk</italic> mRNA in liver of WT, Rev-KO, and TgRev mice. (A&#x02013;C), left panels, mRNA levels were determined around the clock from pooled whole-cell RNAs (four to six animals per time point) or (A&#x02013;C), right panel, from individual animals at ZT0 and ZT12 (data represent mean values&#x000b1;SEM; WT, <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;3; TgRev, <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;4). (D) Glucose tolerance test on WT and Rev-KO mice (data represent mean values&#x000b1;SEM, <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;9). (E) Blood glucose concentration determined at ZT12 and ZT20 for WT and Rev-KO mice (data represent means&#x000b1;SEM; ZT12, WT, <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;14 and Rev-KO, <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;12; ZT20, WT, <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;8 and Rev-KO, <italic>n</italic>&#x0200a;&#x0003d;&#x0200a;8).</p><p>(0.45 MB EPS)</p></caption><media xlink:href="pbio.1000181.s010.eps" mimetype="application" mime-subtype="postscript"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s011"><label>Figure S11</label><caption><p><bold>Temporal hepatic expression of </bold><bold><italic>E4bp4/Nfil3</italic></bold><bold> transcripts in WT and E4bp4-KO mice, as monitored by quantitative RT-PCR.</bold> Data represent the mean&#x000b1;SEM (<italic>n</italic>&#x0200a;&#x0003d;&#x0200a;4), number values below detection level.</p><p>(0.29 MB EPS)</p></caption><media xlink:href="pbio.1000181.s011.eps" mimetype="application" mime-subtype="postscript"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s012"><label>Table S1</label><caption><p><bold>Genes up-regulated in Rev-KO mice.</bold></p><p>(0.03 MB XLS)</p></caption><media xlink:href="pbio.1000181.s012.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s013"><label>Table S2</label><caption><p><bold>Genes down-regulated in Rev-KO mice.</bold> In <xref ref-type="supplementary-material" rid="pbio.1000181.s012">Table S1</xref> and S2 the fold changes (FC) are the average ratios between transcript accumulation levels (Rev-KO/WT) of all nine comparisons (see experimental procedures for the analysis of Affymetrix microarray data). The estimated fold changes were verified by Northern blot (Nb) or quantitative RT-PCR experiments. The minus signs in Table S2 indicate that these transcripts accumulated to lower levels in Rev-KO mice than in WT mice.</p><p>(0.03 MB XLS)</p></caption><media xlink:href="pbio.1000181.s013.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pbio.1000181.s014"><label>Table S3</label><caption><p><bold>Nucleotide sequences of gene-specific primers used in this study.</bold></p><p>(0.02 MB XLS)</p></caption><media xlink:href="pbio.1000181.s014.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We are indebted to Andrew Thomas Look (Dana-Farber Cancer Institute, Harvard Medical School, Boston) for providing <italic>E4bp4/Nfil3</italic> knock-out mice, and David J. Mangelsdorf (University of Texas Southwestern Medical Center, Dallas) for providing <italic>Lxr</italic> knock-out mice. We would also like to thank Norio Ishida (National Institute of Advanced Industrial Science and Technology, Tsukuba 305-8566, Japan) for his generous gift of the E4BP4/NFIL3 expression vector; Myl&#x000e8;ne Docquier and Didier Chollet (NCCR Genomics Platform, Geneva) for their help in performing real-time RT-PCR experiments; Marianne Carrard (CIG Metabolics Platform, Lausanne) for her assistance in performing the blood chemistry; and Nicolas Roggli for his expert preparation of the artwork.</p></ack><ref-list><title>References</title><ref id="pbio.1000181-Gachon1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gachon</surname><given-names>F</given-names></name><name><surname>Nagoshi</surname><given-names>E</given-names></name><name><surname>Brown</surname><given-names>S. A</given-names></name><name><surname>Ripperger</surname><given-names>J</given-names></name><name><surname>Schibler</surname><given-names>U</given-names></name></person-group><year>2004</year><article-title>The mammalian circadian timing system: from gene expression to physiology.</article-title><source>Chromosoma</source><volume>113</volume><fpage>103</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">15338234</pub-id></mixed-citation></ref><ref id="pbio.1000181-Reppert1"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reppert</surname><given-names>S. M</given-names></name><name><surname>Weaver</surname><given-names>D. R</given-names></name></person-group><year>2002</year><article-title>Coordination of circadian timing in mammals.</article-title><source>Nature</source><volume>418</volume><fpage>935</fpage><lpage>941</lpage><pub-id pub-id-type="pmid">12198538</pub-id></mixed-citation></ref><ref id="pbio.1000181-Balsalobre1"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balsalobre</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>S. A</given-names></name><name><surname>Marcacci</surname><given-names>L</given-names></name><name><surname>Tronche</surname><given-names>F</given-names></name><name><surname>Kellendonk</surname><given-names>C</given-names></name><etal/></person-group><year>2000</year><article-title>Resetting of circadian time in peripheral tissues by glucocorticoid signaling.</article-title><source>Science</source><volume>289</volume><fpage>2344</fpage><lpage>2347</lpage><pub-id pub-id-type="pmid">11009419</pub-id></mixed-citation></ref><ref id="pbio.1000181-Brown1"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>S. A</given-names></name><name><surname>Zumbrunn</surname><given-names>G</given-names></name><name><surname>Fleury-Olela</surname><given-names>F</given-names></name><name><surname>Preitner</surname><given-names>N</given-names></name><name><surname>Schibler</surname><given-names>U</given-names></name></person-group><year>2002</year><article-title>Rhythms of mammalian body temperature can sustain peripheral circadian clocks.</article-title><source>Curr Biol</source><volume>12</volume><fpage>1574</fpage><lpage>1583</lpage><pub-id pub-id-type="pmid">12372249</pub-id></mixed-citation></ref><ref id="pbio.1000181-LeMinh1"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Minh</surname><given-names>N</given-names></name><name><surname>Damiola</surname><given-names>F</given-names></name><name><surname>Tronche</surname><given-names>F</given-names></name><name><surname>Schutz</surname><given-names>G</given-names></name><name><surname>Schibler</surname><given-names>U</given-names></name></person-group><year>2001</year><article-title>Glucocorticoid hormones inhibit food-induced phase-shifting of peripheral circadian oscillators.</article-title><source>Embo J</source><volume>20</volume><fpage>7128</fpage><lpage>7136</lpage><pub-id pub-id-type="pmid">11742989</pub-id></mixed-citation></ref><ref id="pbio.1000181-Stokkan1"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stokkan</surname><given-names>K. A</given-names></name><name><surname>Yamazaki</surname><given-names>S</given-names></name><name><surname>Tei</surname><given-names>H</given-names></name><name><surname>Sakaki</surname><given-names>Y</given-names></name><name><surname>Menaker</surname><given-names>M</given-names></name></person-group><year>2001</year><article-title>Entrainment of the circadian clock in the liver by feeding.</article-title><source>Science</source><volume>291</volume><fpage>490</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">11161204</pub-id></mixed-citation></ref><ref id="pbio.1000181-DeBruyne1"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeBruyne</surname><given-names>J. P</given-names></name><name><surname>Weaver</surname><given-names>D. R</given-names></name><name><surname>Reppert</surname><given-names>S. M</given-names></name></person-group><year>2007</year><article-title>CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock.</article-title><source>Nat Neurosci</source><volume>10</volume><fpage>543</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">17417633</pub-id></mixed-citation></ref><ref id="pbio.1000181-Preitner1"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preitner</surname><given-names>N</given-names></name><name><surname>Damiola</surname><given-names>F</given-names></name><name><surname>Lopez-Molina</surname><given-names>L</given-names></name><name><surname>Zakany</surname><given-names>J</given-names></name><name><surname>Duboule</surname><given-names>D</given-names></name><etal/></person-group><year>2002</year><article-title>The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator.</article-title><source>Cell</source><volume>110</volume><fpage>251</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">12150932</pub-id></mixed-citation></ref><ref id="pbio.1000181-Akhtar1"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhtar</surname><given-names>R. A</given-names></name><name><surname>Reddy</surname><given-names>A. B</given-names></name><name><surname>Maywood</surname><given-names>E. S</given-names></name><name><surname>Clayton</surname><given-names>J. D</given-names></name><name><surname>King</surname><given-names>V. M</given-names></name><etal/></person-group><year>2002</year><article-title>Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus.</article-title><source>Curr Biol</source><volume>12</volume><fpage>540</fpage><lpage>550</lpage><pub-id pub-id-type="pmid">11937022</pub-id></mixed-citation></ref><ref id="pbio.1000181-Hughes1"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>M. E</given-names></name><name><surname>DiTacchio</surname><given-names>L</given-names></name><name><surname>Hayes</surname><given-names>K. R</given-names></name><name><surname>Vollmers</surname><given-names>C</given-names></name><name><surname>Pulivarthy</surname><given-names>S</given-names></name><etal/></person-group><year>2009</year><article-title>Harmonics of circadian gene transcription in mammals.</article-title><source>PLoS Genet</source><volume>5</volume><fpage>e1000442</fpage><comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1000442">10.1371/journal.pgen.1000442</ext-link></comment><pub-id pub-id-type="pmid">19343201</pub-id></mixed-citation></ref><ref id="pbio.1000181-Kornmann1"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kornmann</surname><given-names>B</given-names></name><name><surname>Schaad</surname><given-names>O</given-names></name><name><surname>Bujard</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>J. S</given-names></name><name><surname>Schibler</surname><given-names>U</given-names></name></person-group><year>2007</year><article-title>System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock.</article-title><source>PLoS Biol</source><volume>5</volume><fpage>e34</fpage><comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pbio.0050034">10.1371/journal.pbio.0050034</ext-link></comment><pub-id pub-id-type="pmid">17298173</pub-id></mixed-citation></ref><ref id="pbio.1000181-Panda1"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname><given-names>S</given-names></name><name><surname>Antoch</surname><given-names>M. P</given-names></name><name><surname>Miller</surname><given-names>B. H</given-names></name><name><surname>Su</surname><given-names>A. I</given-names></name><name><surname>Schook</surname><given-names>A. B</given-names></name><etal/></person-group><year>2002</year><article-title>Coordinated transcription of key pathways in the mouse by the circadian clock.</article-title><source>Cell</source><volume>109</volume><fpage>307</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">12015981</pub-id></mixed-citation></ref><ref id="pbio.1000181-Storch1"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storch</surname><given-names>K. F</given-names></name><name><surname>Lipan</surname><given-names>O</given-names></name><name><surname>Leykin</surname><given-names>I</given-names></name><name><surname>Viswanathan</surname><given-names>N</given-names></name><name><surname>Davis</surname><given-names>F. C</given-names></name><etal/></person-group><year>2002</year><article-title>Extensive and divergent circadian gene expression in liver and heart.</article-title><source>Nature</source><volume>417</volume><fpage>78</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">11967526</pub-id></mixed-citation></ref><ref id="pbio.1000181-Gachon2"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gachon</surname><given-names>F</given-names></name><name><surname>Olela</surname><given-names>F. F</given-names></name><name><surname>Schaad</surname><given-names>O</given-names></name><name><surname>Descombes</surname><given-names>P</given-names></name><name><surname>Schibler</surname><given-names>U</given-names></name></person-group><year>2006</year><article-title>The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification.&#x0005b;see comment&#x0005d;.</article-title><source>Cell Metabolism</source><volume>4</volume><fpage>25</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">16814730</pub-id></mixed-citation></ref><ref id="pbio.1000181-Gielen1"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gielen</surname><given-names>J</given-names></name><name><surname>Van Cantfort</surname><given-names>J</given-names></name><name><surname>Robaye</surname><given-names>B</given-names></name><name><surname>Renson</surname><given-names>J</given-names></name></person-group><year>1975</year><article-title>Rat-liver cholesterol 7alpha-hydroxylase. 3. New results about its circadian rhythm.</article-title><source>Eur J Biochem</source><volume>55</volume><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">1175607</pub-id></mixed-citation></ref><ref id="pbio.1000181-Duane1"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duane</surname><given-names>W. C</given-names></name><name><surname>Levitt</surname><given-names>D. G</given-names></name><name><surname>Mueller</surname><given-names>S. M</given-names></name><name><surname>Behrens</surname><given-names>J. C</given-names></name></person-group><year>1983</year><article-title>Regulation of bile acid synthesis in man. Presence of a diurnal rhythm.</article-title><source>J Clin Invest</source><volume>72</volume><fpage>1930</fpage><lpage>1936</lpage><pub-id pub-id-type="pmid">6417166</pub-id></mixed-citation></ref><ref id="pbio.1000181-Edwards1"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>P. A</given-names></name><name><surname>Muroya</surname><given-names>H</given-names></name><name><surname>Gould</surname><given-names>R. G</given-names></name></person-group><year>1972</year><article-title>In vivo demonstration of the circadian thythm of cholesterol biosynthesis in the liver and intestine of the rat.</article-title><source>J Lipid Res</source><volume>13</volume><fpage>396</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">5025468</pub-id></mixed-citation></ref><ref id="pbio.1000181-Vallett1"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallett</surname><given-names>S. M</given-names></name><name><surname>Sanchez</surname><given-names>H. B</given-names></name><name><surname>Rosenfeld</surname><given-names>J. M</given-names></name><name><surname>Osborne</surname><given-names>T. F</given-names></name></person-group><year>1996</year><article-title>A direct role for sterol regulatory element binding protein in activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene.</article-title><source>J Biol Chem</source><volume>271</volume><fpage>12247</fpage><lpage>12253</lpage><pub-id pub-id-type="pmid">8647822</pub-id></mixed-citation></ref><ref id="pbio.1000181-Magana1"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magana</surname><given-names>M. M</given-names></name><name><surname>Osborne</surname><given-names>T. F</given-names></name></person-group><year>1996</year><article-title>Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter.</article-title><source>J Biol Chem</source><volume>271</volume><fpage>32689</fpage><lpage>32694</lpage><pub-id pub-id-type="pmid">8955100</pub-id></mixed-citation></ref><ref id="pbio.1000181-Nohturfft1"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nohturfft</surname><given-names>A</given-names></name><name><surname>Yabe</surname><given-names>D</given-names></name><name><surname>Goldstein</surname><given-names>J. L</given-names></name><name><surname>Brown</surname><given-names>M. S</given-names></name><name><surname>Espenshade</surname><given-names>P. J</given-names></name></person-group><year>2000</year><article-title>Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes.</article-title><source>Cell</source><volume>102</volume><fpage>315</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">10975522</pub-id></mixed-citation></ref><ref id="pbio.1000181-Yang1"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Espenshade</surname><given-names>P. J</given-names></name><name><surname>Wright</surname><given-names>M. E</given-names></name><name><surname>Yabe</surname><given-names>D</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><etal/></person-group><year>2002</year><article-title>Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER.</article-title><source>Cell</source><volume>110</volume><fpage>489</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">12202038</pub-id></mixed-citation></ref><ref id="pbio.1000181-Yabe1"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yabe</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>M. S</given-names></name><name><surname>Goldstein</surname><given-names>J. L</given-names></name></person-group><year>2002</year><article-title>Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins.</article-title><volume>99</volume><fpage>12753</fpage><lpage>12758</lpage></mixed-citation></ref><ref id="pbio.1000181-Radhakrishnan1"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radhakrishnan</surname><given-names>A</given-names></name><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Kwon</surname><given-names>H. J</given-names></name><name><surname>Brown</surname><given-names>M. S</given-names></name><name><surname>Goldstein</surname><given-names>J. L</given-names></name></person-group><year>2007</year><article-title>Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig.&#x0005b;see comment&#x0005d;.</article-title><source>Proc Natl Acad Sci U S A</source><volume>104</volume><fpage>6511</fpage><lpage>6518</lpage><pub-id pub-id-type="pmid">17428920</pub-id></mixed-citation></ref><ref id="pbio.1000181-Goldstein1"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>J. L</given-names></name><name><surname>DeBose-Boyd</surname><given-names>R. A</given-names></name><name><surname>Brown</surname><given-names>M. S</given-names></name></person-group><year>2006</year><article-title>Protein sensors for membrane sterols.</article-title><source>Cell</source><volume>124</volume><fpage>35</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">16413480</pub-id></mixed-citation></ref><ref id="pbio.1000181-Moore1"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>J. T</given-names></name><name><surname>Goodwin</surname><given-names>B</given-names></name><name><surname>Willson</surname><given-names>T. M</given-names></name><name><surname>Kliewer</surname><given-names>S. A</given-names></name></person-group><year>2002</year><article-title>Nuclear receptor regulation of genes involved in bile acid metabolism.</article-title><source>Crit Rev Eukaryot Gene Expr</source><volume>12</volume><fpage>119</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">12434926</pub-id></mixed-citation></ref><ref id="pbio.1000181-Russell1"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>D. W</given-names></name></person-group><year>1999</year><article-title>Nuclear orphan receptors control cholesterol catabolism.</article-title><source>Cell</source><volume>97</volume><fpage>539</fpage><lpage>542</lpage><pub-id pub-id-type="pmid">10367881</pub-id></mixed-citation></ref><ref id="pbio.1000181-Janowski1"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janowski</surname><given-names>B. A</given-names></name><name><surname>Willy</surname><given-names>P. J</given-names></name><name><surname>Devi</surname><given-names>T. R</given-names></name><name><surname>Falck</surname><given-names>J. R</given-names></name><name><surname>Mangelsdorf</surname><given-names>D. J</given-names></name></person-group><year>1996</year><article-title>An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha.</article-title><source>Nature</source><volume>383</volume><fpage>728</fpage><lpage>731</lpage><pub-id pub-id-type="pmid">8878485</pub-id></mixed-citation></ref><ref id="pbio.1000181-Peet1"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peet</surname><given-names>D. J</given-names></name><name><surname>Turley</surname><given-names>S. D</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Janowski</surname><given-names>B. A</given-names></name><name><surname>Lobaccaro</surname><given-names>J. M</given-names></name><etal/></person-group><year>1998</year><article-title>Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha.</article-title><source>Cell</source><volume>93</volume><fpage>693</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">9630215</pub-id></mixed-citation></ref><ref id="pbio.1000181-Inagaki1"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inagaki</surname><given-names>T</given-names></name><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>Moschetta</surname><given-names>A</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Cummins</surname><given-names>C. L</given-names></name><etal/></person-group><year>2005</year><article-title>Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.</article-title><source>Cell Metab</source><volume>2</volume><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">16213224</pub-id></mixed-citation></ref><ref id="pbio.1000181-Parks1"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parks</surname><given-names>D. J</given-names></name><name><surname>Blanchard</surname><given-names>S. G</given-names></name><name><surname>Bledsoe</surname><given-names>R. K</given-names></name><name><surname>Chandra</surname><given-names>G</given-names></name><name><surname>Consler</surname><given-names>T. G</given-names></name><etal/></person-group><year>1999</year><article-title>Bile acids: natural ligands for an orphan nuclear receptor.&#x0005b;see comment&#x0005d;.</article-title><source>Science</source><volume>284</volume><fpage>1365</fpage><lpage>1368</lpage><pub-id pub-id-type="pmid">10334993</pub-id></mixed-citation></ref><ref id="pbio.1000181-Sinal1"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinal</surname><given-names>C. J</given-names></name><name><surname>Tohkin</surname><given-names>M</given-names></name><name><surname>Miyata</surname><given-names>M</given-names></name><name><surname>Ward</surname><given-names>J. M</given-names></name><name><surname>Lambert</surname><given-names>G</given-names></name><etal/></person-group><year>2000</year><article-title>Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.</article-title><source>Cell</source><volume>102</volume><fpage>731</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">11030617</pub-id></mixed-citation></ref><ref id="pbio.1000181-Duez1"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duez</surname><given-names>H</given-names></name><name><surname>Veen</surname><given-names>J. V</given-names></name><name><surname>Duhem</surname><given-names>C</given-names></name><name><surname>Pourcet</surname><given-names>B</given-names></name><name><surname>Touvier</surname><given-names>T</given-names></name><etal/></person-group><year>2008</year><article-title>Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha.</article-title><source>Gastroenterology</source><volume>135</volume><fpage>689</fpage><lpage>698</lpage><pub-id pub-id-type="pmid">18565334</pub-id></mixed-citation></ref><ref id="pbio.1000181-Harding1"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>H. P</given-names></name><name><surname>Atkins</surname><given-names>G. B</given-names></name><name><surname>Jaffe</surname><given-names>A. B</given-names></name><name><surname>Seo</surname><given-names>W. J</given-names></name><name><surname>Lazar</surname><given-names>M. A</given-names></name></person-group><year>1997</year><article-title>Transcriptional activation and repression by RORalpha, an orphan nuclear receptor required for cerebellar development.</article-title><source>Mol Endocrinol</source><volume>11</volume><fpage>1737</fpage><lpage>1746</lpage><pub-id pub-id-type="pmid">9328355</pub-id></mixed-citation></ref><ref id="pbio.1000181-Horton1"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horton</surname><given-names>J. D</given-names></name><name><surname>Shah</surname><given-names>N. A</given-names></name><name><surname>Warrington</surname><given-names>J. A</given-names></name><name><surname>Anderson</surname><given-names>N. N</given-names></name><name><surname>Park</surname><given-names>S. W</given-names></name><etal/></person-group><year>2003</year><article-title>Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>12027</fpage><lpage>12032</lpage><pub-id pub-id-type="pmid">14512514</pub-id></mixed-citation></ref><ref id="pbio.1000181-Hegarty1"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegarty</surname><given-names>B. D</given-names></name><name><surname>Bobard</surname><given-names>A</given-names></name><name><surname>Hainault</surname><given-names>I</given-names></name><name><surname>Ferre</surname><given-names>P</given-names></name><name><surname>Bossard</surname><given-names>P</given-names></name><etal/></person-group><year>2005</year><article-title>Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c.</article-title><source>Proc Natl Acad Sci U S A</source><volume>102</volume><fpage>791</fpage><lpage>796</lpage><pub-id pub-id-type="pmid">15637161</pub-id></mixed-citation></ref><ref id="pbio.1000181-Horton2"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horton</surname><given-names>J. D</given-names></name><name><surname>Bashmakov</surname><given-names>Y</given-names></name><name><surname>Shimomura</surname><given-names>I</given-names></name><name><surname>Shimano</surname><given-names>H</given-names></name></person-group><year>1998</year><article-title>Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice.</article-title><source>Proc Natl Acad Sci U S A</source><volume>95</volume><fpage>5987</fpage><lpage>5992</lpage><pub-id pub-id-type="pmid">9600904</pub-id></mixed-citation></ref><ref id="pbio.1000181-Ou1"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>J</given-names></name><name><surname>Tu</surname><given-names>H</given-names></name><name><surname>Shan</surname><given-names>B</given-names></name><name><surname>Luk</surname><given-names>A</given-names></name><name><surname>DeBose-Boyd</surname><given-names>R. A</given-names></name><etal/></person-group><year>2001</year><article-title>Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR.</article-title><source>Proc Natl Acad Sci U S A</source><volume>98</volume><fpage>6027</fpage><lpage>6032</lpage><pub-id pub-id-type="pmid">11371634</pub-id></mixed-citation></ref><ref id="pbio.1000181-Sampath1"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampath</surname><given-names>H</given-names></name><name><surname>Ntambi</surname><given-names>J. M</given-names></name></person-group><year>2004</year><article-title>Polyunsaturated fatty acid regulation of gene expression.</article-title><source>Nutr Rev</source><volume>62</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">15497766</pub-id></mixed-citation></ref><ref id="pbio.1000181-Worgall1"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worgall</surname><given-names>T. S</given-names></name><name><surname>Sturley</surname><given-names>S. L</given-names></name><name><surname>Seo</surname><given-names>T</given-names></name><name><surname>Osborne</surname><given-names>T. F</given-names></name><name><surname>Deckelbaum</surname><given-names>R. J</given-names></name></person-group><year>1998</year><article-title>Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein.</article-title><source>J Biol Chem</source><volume>273</volume><fpage>25537</fpage><lpage>25540</lpage><pub-id pub-id-type="pmid">9748213</pub-id></mixed-citation></ref><ref id="pbio.1000181-Shimomura1"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimomura</surname><given-names>I</given-names></name><name><surname>Bashmakov</surname><given-names>Y</given-names></name><name><surname>Ikemoto</surname><given-names>S</given-names></name><name><surname>Horton</surname><given-names>J. D</given-names></name><name><surname>Brown</surname><given-names>M. S</given-names></name><etal/></person-group><year>1999</year><article-title>Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes.</article-title><source>Proc Natl Acad Sci U S A</source><volume>96</volume><fpage>13656</fpage><lpage>13661</lpage><pub-id pub-id-type="pmid">10570128</pub-id></mixed-citation></ref><ref id="pbio.1000181-Yabe2"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yabe</surname><given-names>D</given-names></name><name><surname>Komuro</surname><given-names>R</given-names></name><name><surname>Liang</surname><given-names>G</given-names></name><name><surname>Goldstein</surname><given-names>J. L</given-names></name><name><surname>Brown</surname><given-names>M. S</given-names></name></person-group><year>2003</year><article-title>Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis.</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>3155</fpage><lpage>3160</lpage><pub-id pub-id-type="pmid">12624180</pub-id></mixed-citation></ref><ref id="pbio.1000181-Cohen1"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J. C</given-names></name><name><surname>Kiss</surname><given-names>R. S</given-names></name><name><surname>Pertsemlidis</surname><given-names>A</given-names></name><name><surname>Marcel</surname><given-names>Y. L</given-names></name><name><surname>McPherson</surname><given-names>R</given-names></name><etal/></person-group><year>2004</year><article-title>Multiple rare alleles contribute to low plasma levels of HDL cholesterol.</article-title><source>Science</source><volume>305</volume><fpage>869</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">15297675</pub-id></mixed-citation></ref><ref id="pbio.1000181-Jin1"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>W</given-names></name><name><surname>Millar</surname><given-names>J. S</given-names></name><name><surname>Broedl</surname><given-names>U</given-names></name><name><surname>Glick</surname><given-names>J. M</given-names></name><name><surname>Rader</surname><given-names>D. J</given-names></name></person-group><year>2003</year><article-title>Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo.&#x0005b;see comment&#x0005d;.</article-title><source>J Clin Invest</source><volume>111</volume><fpage>357</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">12569161</pub-id></mixed-citation></ref><ref id="pbio.1000181-Raspe1"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raspe</surname><given-names>E</given-names></name><name><surname>Duez</surname><given-names>H</given-names></name><name><surname>Mansen</surname><given-names>A</given-names></name><name><surname>Fontaine</surname><given-names>C</given-names></name><name><surname>Fievet</surname><given-names>C</given-names></name><etal/></person-group><year>2002</year><article-title>Identification of Rev-erbalpha as a physiological repressor of apoC-III gene transcription.</article-title><source>J Lipid Res</source><volume>43</volume><fpage>2172</fpage><lpage>2179</lpage><pub-id pub-id-type="pmid">12454280</pub-id></mixed-citation></ref><ref id="pbio.1000181-Duane2"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duane</surname><given-names>W. C</given-names></name><name><surname>Gilberstadt</surname><given-names>M. L</given-names></name><name><surname>Wiegand</surname><given-names>D. M</given-names></name></person-group><year>1979</year><article-title>Diurnal rhythms of bile acid production in the rat.</article-title><source>Am J Physiol</source><volume>236</volume><fpage>R175</fpage><lpage>R179</lpage><pub-id pub-id-type="pmid">426094</pub-id></mixed-citation></ref><ref id="pbio.1000181-Cowell1"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowell</surname><given-names>I. G</given-names></name><name><surname>Skinner</surname><given-names>A</given-names></name><name><surname>Hurst</surname><given-names>H. C</given-names></name></person-group><year>1992</year><article-title>Transcriptional repression by a novel member of the bZIP family of transcription factors.</article-title><source>Mol Cell Biol</source><volume>12</volume><fpage>3070</fpage><lpage>3077</lpage><pub-id pub-id-type="pmid">1620116</pub-id></mixed-citation></ref><ref id="pbio.1000181-Lavery1"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavery</surname><given-names>D. J</given-names></name><name><surname>Schibler</surname><given-names>U</given-names></name></person-group><year>1993</year><article-title>Circadian transcription of the cholesterol 7 alpha hydroxylase gene may involve the liver-enriched bZIP protein DBP.</article-title><source>Genes Dev</source><volume>7</volume><fpage>1871</fpage><lpage>1884</lpage><pub-id pub-id-type="pmid">8405996</pub-id></mixed-citation></ref><ref id="pbio.1000181-Lee1"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y. H</given-names></name><name><surname>Alberta</surname><given-names>J. A</given-names></name><name><surname>Gonzalez</surname><given-names>F. J</given-names></name><name><surname>Waxman</surname><given-names>D. J</given-names></name></person-group><year>1994</year><article-title>Multiple, functional DBP sites on the promoter of the cholesterol 7 alpha-hydroxylase P450 gene, CYP7. Proposed role in diurnal regulation of liver gene expression.</article-title><source>J Biol Chem</source><volume>269</volume><fpage>14681</fpage><lpage>14689</lpage><pub-id pub-id-type="pmid">8182075</pub-id></mixed-citation></ref><ref id="pbio.1000181-Noshiro1"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noshiro</surname><given-names>M</given-names></name><name><surname>Usui</surname><given-names>E</given-names></name><name><surname>Kawamoto</surname><given-names>T</given-names></name><name><surname>Kubo</surname><given-names>H</given-names></name><name><surname>Fujimoto</surname><given-names>K</given-names></name><etal/></person-group><year>2007</year><article-title>Multiple mechanisms regulate circadian expression of the gene for cholesterol 7alpha-hydroxylase (Cyp7a), a key enzyme in hepatic bile acid biosynthesis.</article-title><source>J Biol Rhythms</source><volume>22</volume><fpage>299</fpage><lpage>311</lpage><pub-id pub-id-type="pmid">17660447</pub-id></mixed-citation></ref><ref id="pbio.1000181-Takeuchi1"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>N</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Yamamura</surname><given-names>Y</given-names></name></person-group><year>1974</year><article-title>Regulation of cholesterol 7 alpha-hydroxylation by cholesterol synthesis in rat liver.</article-title><source>Atherosclerosis</source><volume>20</volume><fpage>481</fpage><lpage>494</lpage><pub-id pub-id-type="pmid">4429618</pub-id></mixed-citation></ref><ref id="pbio.1000181-Jones1"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>M. P</given-names></name><name><surname>Pandak</surname><given-names>W. M</given-names></name><name><surname>Heuman</surname><given-names>D. M</given-names></name><name><surname>Chiang</surname><given-names>J. Y</given-names></name><name><surname>Hylemon</surname><given-names>P. B</given-names></name><etal/></person-group><year>1993</year><article-title>Cholesterol 7 alpha-hydroxylase: evidence for transcriptional regulation by cholesterol or metabolic products of cholesterol in the rat.</article-title><source>J Lipid Res</source><volume>34</volume><fpage>885</fpage><lpage>892</lpage><pub-id pub-id-type="pmid">8354954</pub-id></mixed-citation></ref><ref id="pbio.1000181-Pandak1"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandak</surname><given-names>W. M</given-names></name><name><surname>Heuman</surname><given-names>D. M</given-names></name><name><surname>Hylemon</surname><given-names>P. B</given-names></name><name><surname>Vlahcevic</surname><given-names>Z. R</given-names></name></person-group><year>1990</year><article-title>Regulation of bile acid synthesis. IV. Interrelationship between cholesterol and bile acid biosynthesis pathways.</article-title><source>J Lipid Res</source><volume>31</volume><fpage>79</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">2313206</pub-id></mixed-citation></ref><ref id="pbio.1000181-Pandak2"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandak</surname><given-names>W. M</given-names></name><name><surname>Vlahcevic</surname><given-names>Z. R</given-names></name><name><surname>Heuman</surname><given-names>D. M</given-names></name><name><surname>Hylemon</surname><given-names>P. B</given-names></name></person-group><year>1990</year><article-title>Regulation of bile acid synthesis. V. Inhibition of conversion of 7-dehydrocholesterol to cholesterol is associated with down-regulation of cholesterol 7 alpha-hydroxylase activity and inhibition of bile acid synthesis.</article-title><source>J Lipid Res</source><volume>31</volume><fpage>2149</fpage><lpage>2158</lpage><pub-id pub-id-type="pmid">1708805</pub-id></mixed-citation></ref><ref id="pbio.1000181-Jurevics1"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurevics</surname><given-names>H</given-names></name><name><surname>Hostettler</surname><given-names>J</given-names></name><name><surname>Barrett</surname><given-names>C</given-names></name><name><surname>Morell</surname><given-names>P</given-names></name><name><surname>Toews</surname><given-names>A. D</given-names></name></person-group><year>2000</year><article-title>Diurnal and dietary-induced changes in cholesterol synthesis correlate with levels of mRNA for HMG-CoA reductase.</article-title><source>J Lipid Res</source><volume>41</volume><fpage>1048</fpage><lpage>1054</lpage><pub-id pub-id-type="pmid">10884284</pub-id></mixed-citation></ref><ref id="pbio.1000181-DeBoseBoyd1"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeBose-Boyd</surname><given-names>R. A</given-names></name><name><surname>Ou</surname><given-names>J</given-names></name><name><surname>Goldstein</surname><given-names>J. L</given-names></name><name><surname>Brown</surname><given-names>M. S</given-names></name></person-group><year>2001</year><article-title>Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands.</article-title><source>Proc Natl Acad Sci U S A</source><volume>98</volume><fpage>1477</fpage><lpage>1482</lpage><pub-id pub-id-type="pmid">11171976</pub-id></mixed-citation></ref><ref id="pbio.1000181-Wong1"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>J</given-names></name><name><surname>Quinn</surname><given-names>C. M</given-names></name><name><surname>Gelissen</surname><given-names>I. C</given-names></name><name><surname>Brown</surname><given-names>A. J</given-names></name></person-group><year>2008</year><article-title>Endogenous 24(S),25-epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis.</article-title><source>J Biol Chem</source><volume>283</volume><fpage>700</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">17981807</pub-id></mixed-citation></ref><ref id="pbio.1000181-Huang1"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Qatanani</surname><given-names>M</given-names></name><name><surname>Cuvillier</surname><given-names>J</given-names></name><etal/></person-group><year>2006</year><article-title>Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration.&#x0005b;see comment&#x0005d;.</article-title><source>Science</source><volume>312</volume><fpage>233</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">16614213</pub-id></mixed-citation></ref><ref id="pbio.1000181-Schroepfer1"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroepfer</surname><given-names>G. J</given-names><suffix>Jr</suffix></name></person-group><year>2000</year><article-title>Oxysterols: modulators of cholesterol metabolism and other processes.</article-title><source>Physiol Rev</source><volume>80</volume><fpage>361</fpage><lpage>554</lpage><pub-id pub-id-type="pmid">10617772</pub-id></mixed-citation></ref><ref id="pbio.1000181-Kerr1"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>T. A</given-names></name><name><surname>Saeki</surname><given-names>S</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Schaefer</surname><given-names>K</given-names></name><name><surname>Berdy</surname><given-names>S</given-names></name><etal/></person-group><year>2002</year><article-title>Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis.</article-title><source>Dev Cell</source><volume>2</volume><fpage>713</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">12062084</pub-id></mixed-citation></ref><ref id="pbio.1000181-Kim1"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>I</given-names></name><name><surname>Ahn</surname><given-names>S. H</given-names></name><name><surname>Inagaki</surname><given-names>T</given-names></name><name><surname>Choi</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.</article-title><source>J Lipid Res</source><volume>48</volume><fpage>2664</fpage><lpage>2672</lpage><pub-id pub-id-type="pmid">17720959</pub-id></mixed-citation></ref><ref id="pbio.1000181-Lundasen1"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundasen</surname><given-names>T</given-names></name><name><surname>Galman</surname><given-names>C</given-names></name><name><surname>Angelin</surname><given-names>B</given-names></name><name><surname>Rudling</surname><given-names>M</given-names></name></person-group><year>2006</year><article-title>Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.</article-title><source>J Intern Med</source><volume>260</volume><fpage>530</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">17116003</pub-id></mixed-citation></ref><ref id="pbio.1000181-Hubbert1"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubbert</surname><given-names>M. L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>F. Y</given-names></name><name><surname>Edwards</surname><given-names>P. A</given-names></name></person-group><year>2007</year><article-title>Regulation of hepatic Insig-2 by the farnesoid X receptor.</article-title><source>Mol Endocrinol</source><volume>21</volume><fpage>1359</fpage><lpage>1369</lpage><pub-id pub-id-type="pmid">17440045</pub-id></mixed-citation></ref><ref id="pbio.1000181-Gatfield1"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatfield</surname><given-names>D</given-names></name><name><surname>Le Martelot</surname><given-names>G</given-names></name><name><surname>Vejnar</surname><given-names>C. E</given-names></name><name><surname>Gerlach</surname><given-names>D</given-names></name><name><surname>Schaad</surname><given-names>O</given-names></name><etal/></person-group><year>2009</year><article-title>Integration of microRNA miR-122 in hepatic circadian gene expression.</article-title><source>Genes Dev</source><volume>23</volume><fpage>1313</fpage><lpage>1326</lpage><pub-id pub-id-type="pmid">19487572</pub-id></mixed-citation></ref><ref id="pbio.1000181-Esau1"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esau</surname><given-names>C</given-names></name><name><surname>Davis</surname><given-names>S</given-names></name><name><surname>Murray</surname><given-names>S. F</given-names></name><name><surname>Yu</surname><given-names>X. X</given-names></name><name><surname>Pandey</surname><given-names>S. K</given-names></name><etal/></person-group><year>2006</year><article-title>miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.</article-title><source>Cell Metab</source><volume>3</volume><fpage>87</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">16459310</pub-id></mixed-citation></ref><ref id="pbio.1000181-Krutzfeldt1"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krutzfeldt</surname><given-names>J</given-names></name><name><surname>Rajewsky</surname><given-names>N</given-names></name><name><surname>Braich</surname><given-names>R</given-names></name><name><surname>Rajeev</surname><given-names>K. G</given-names></name><name><surname>Tuschl</surname><given-names>T</given-names></name><etal/></person-group><year>2005</year><article-title>Silencing of microRNAs in vivo with &#x02018;antagomirs&#x02019;.</article-title><source>Nature</source><volume>438</volume><fpage>685</fpage><lpage>689</lpage><pub-id pub-id-type="pmid">16258535</pub-id></mixed-citation></ref><ref id="pbio.1000181-Levi1"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levi</surname><given-names>F</given-names></name><name><surname>Schibler</surname><given-names>U</given-names></name></person-group><year>2007</year><article-title>Circadian rhythms: mechanisms and therapeutic implications.</article-title><source>Annu Rev Pharmacol Toxicol</source><volume>47</volume><fpage>593</fpage><lpage>628</lpage><pub-id pub-id-type="pmid">17209800</pub-id></mixed-citation></ref><ref id="pbio.1000181-Yang2"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Downes</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>R. T</given-names></name><name><surname>Bookout</surname><given-names>A. L</given-names></name><name><surname>He</surname><given-names>W</given-names></name><etal/></person-group><year>2006</year><article-title>Nuclear receptor expression links the circadian clock to metabolism.</article-title><source>Cell</source><volume>126</volume><fpage>801</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">16923398</pub-id></mixed-citation></ref><ref id="pbio.1000181-Chawla1"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chawla</surname><given-names>A</given-names></name><name><surname>Repa</surname><given-names>J. J</given-names></name><name><surname>Evans</surname><given-names>R. M</given-names></name><name><surname>Mangelsdorf</surname><given-names>D. J</given-names></name></person-group><year>2001</year><article-title>Nuclear receptors and lipid physiology: opening the X-files.</article-title><source>Science</source><volume>294</volume><fpage>1866</fpage><lpage>1870</lpage><pub-id pub-id-type="pmid">11729302</pub-id></mixed-citation></ref><ref id="pbio.1000181-Gachon3"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gachon</surname><given-names>F</given-names></name><name><surname>Fonjallaz</surname><given-names>P</given-names></name><name><surname>Damiola</surname><given-names>F</given-names></name><name><surname>Gos</surname><given-names>P</given-names></name><name><surname>Kodama</surname><given-names>T</given-names></name><etal/></person-group><year>2004</year><article-title>The loss of circadian PAR bZip transcription factors results in epilepsy.</article-title><source>Genes Dev</source><volume>18</volume><fpage>1397</fpage><lpage>1412</lpage><pub-id pub-id-type="pmid">15175240</pub-id></mixed-citation></ref><ref id="pbio.1000181-Kalaany1"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalaany</surname><given-names>N. Y</given-names></name><name><surname>Gauthier</surname><given-names>K. C</given-names></name><name><surname>Zavacki</surname><given-names>A. M</given-names></name><name><surname>Mammen</surname><given-names>P. P</given-names></name><name><surname>Kitazume</surname><given-names>T</given-names></name><etal/></person-group><year>2005</year><article-title>LXRs regulate the balance between fat storage and oxidation.</article-title><source>Cell Metab</source><volume>1</volume><fpage>231</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">16054068</pub-id></mixed-citation></ref><ref id="pbio.1000181-Hubbell1"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubbell</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>W. M</given-names></name><name><surname>Mei</surname><given-names>R</given-names></name></person-group><year>2002</year><article-title>Robust estimators for expression analysis.</article-title><source>Bioinformatics</source><volume>18</volume><fpage>1585</fpage><lpage>1592</lpage><pub-id pub-id-type="pmid">12490442</pub-id></mixed-citation></ref><ref id="pbio.1000181-Liu1"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W. M</given-names></name><name><surname>Mei</surname><given-names>R</given-names></name><name><surname>Di</surname><given-names>X</given-names></name><name><surname>Ryder</surname><given-names>T. B</given-names></name><name><surname>Hubbell</surname><given-names>E</given-names></name><etal/></person-group><year>2002</year><article-title>Analysis of high density expression microarrays with signed-rank call algorithms.</article-title><source>Bioinformatics</source><volume>18</volume><fpage>1593</fpage><lpage>1599</lpage><pub-id pub-id-type="pmid">12490443</pub-id></mixed-citation></ref><ref id="pbio.1000181-Vandesompele1"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandesompele</surname><given-names>J</given-names></name><name><surname>De Preter</surname><given-names>K</given-names></name><name><surname>Pattyn</surname><given-names>F</given-names></name><name><surname>Poppe</surname><given-names>B</given-names></name><name><surname>Van Roy</surname><given-names>N</given-names></name><etal/></person-group><year>2002</year><article-title>Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.</article-title><source>Genome Biol</source><volume>3</volume><fpage>RESEARCH0034</fpage><pub-id pub-id-type="pmid">12184808</pub-id></mixed-citation></ref><ref id="pbio.1000181-Mashige1"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mashige</surname><given-names>F</given-names></name><name><surname>Imai</surname><given-names>K</given-names></name><name><surname>Osuga</surname><given-names>T</given-names></name></person-group><year>1976</year><article-title>A simple and sensitive assay of total serum bile acids.</article-title><source>Clin Chim Acta</source><volume>70</volume><fpage>79</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">947625</pub-id></mixed-citation></ref><ref id="pbio.1000181-Kruth1"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kruth</surname><given-names>H. S</given-names></name><name><surname>Blanchette-Mackie</surname><given-names>J</given-names></name><name><surname>Avigan</surname><given-names>J</given-names></name><name><surname>Gamble</surname><given-names>W</given-names></name><name><surname>Vaughan</surname><given-names>M</given-names></name></person-group><year>1982</year><article-title>Subcellular localization and quantification of cholesterol in cultured human fibroblasts exposed to human low density lipoprotein.</article-title><source>J Lipid Res</source><volume>23</volume><fpage>1128</fpage><lpage>1135</lpage><pub-id pub-id-type="pmid">7175370</pub-id></mixed-citation></ref><ref id="pbio.1000181-Bligh1"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bligh</surname><given-names>E. G</given-names></name><name><surname>Dyer</surname><given-names>W. J</given-names></name></person-group><year>1959</year><article-title>A rapid method of total lipid extraction and purification.</article-title><source>Can J Biochem Physiol</source><volume>37</volume><fpage>911</fpage><lpage>917</lpage><pub-id pub-id-type="pmid">13671378</pub-id></mixed-citation></ref><ref id="pbio.1000181-Gill1"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>G</given-names></name><name><surname>Ptashne</surname><given-names>M</given-names></name></person-group><year>1988</year><article-title>Negative effect of the transcriptional activator GAL4.</article-title><source>Nature</source><volume>334</volume><fpage>721</fpage><lpage>724</lpage><pub-id pub-id-type="pmid">3412449</pub-id></mixed-citation></ref></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>AACS</term><def><p>acetoacetyl-CoA synthetase</p></def></def-item><def-item><term>CYP7A1</term><def><p>cytochrome P450 7&#x003b1;-hydroxylase</p></def></def-item><def-item><term>DBP</term><def><p>albumin D-site-binding protein</p></def></def-item><def-item><term>HLF</term><def><p>hepatic leukemia factor</p></def></def-item><def-item><term>Hmgcr</term><def><p>Hmg-CoA reductase</p></def></def-item><def-item><term>INSIG</term><def><p>insulin-induced gene</p></def></def-item><def-item><term>LDL</term><def><p>low-density lipoprotein</p></def></def-item><def-item><term>Rev-KO</term><def><p><italic>Rev-erb</italic>&#x003b1; knock-out mice</p></def></def-item><def-item><term>RT</term><def><p>reverse transcriptase</p></def></def-item><def-item><term>SCAP</term><def><p>SREBP cleavage activating protein</p></def></def-item><def-item><term>SCN</term><def><p>suprachiasmatic nucleus</p></def></def-item><def-item><term>SEM</term><def><p>standard error of the mean</p></def></def-item><def-item><term>SHP</term><def><p>small heterodimer partner</p></def></def-item><def-item><term>SREBP</term><def><p>sterol regulatory element-binding protein</p></def></def-item><def-item><term>TEF</term><def><p>thyrotroph embryonic factor</p></def></def-item><def-item><term>TgRev</term><def><p>transgenic mice that overexpress hepatic REV-ERB&#x003b1; throughout the day</p></def></def-item><def-item><term>WT</term><def><p>wild type</p></def></def-item><def-item><term>ZT</term><def><p>Zeitgeber time</p></def></def-item></def-list></glossary><fn-group><fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p>This research was supported by the Swiss National Foundation (through an individual research grant to U.S. and the National Center of Competence in Research Program Frontiers in Genetics), the State of Geneva, the Louis Jeantet Foundation of Medicine, the Bonizzi-Theler Stiftung, and the 6th European Framework Project EUCLOCK. D. G. received long-term fellowships from The Federation of European Biochemical Societies (FEBS) and The International Human Frontier Science Program Organization (HFSP). Research in A. M.'s laboratory is funded by the Italian Association for Cancer Research (AIRC, Milan, Italy), the European Research Council Starting Independent Grant - IDEAS 2008, the European Community's Seventh Framework Programme FP7/2007 - 20013 under Grant Agreement No. 202272 (LipidomicNet), Italian Ministry of Health and Education (Finanziamenti per la Ricerca di Base), Cariplo Fundation Milan, Telethon Fundation (GGP08259). G. Lo Sasso is a fellow of AIRC-FIRC (Milan, Italy). Thierry Claudel was supported by the SFB LIPOTOX, grant n&#x000b0; F30008-B05, funded by the Austrian Science Foundation (FWF)</p></fn></fn-group></back></article>